BEGIN:VCALENDAR VERSION:2.0 PRODID:-//KESHO - ECPv6.15.20//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:KESHO X-ORIGINAL-URL:https://kesho-kenya.org X-WR-CALDESC:Events for KESHO REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:Africa/Nairobi BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0300 TZNAME:EAT DTSTART:20210101T000000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20221209T190000 DTEND;TZID=Africa/Nairobi:20221209T203000 DTSTAMP:20260423T224351 CREATED:20230524T220834Z LAST-MODIFIED:20230620T115111Z UID:7869-1670612400-1670617800@kesho-kenya.org SUMMARY:PROSTATE CANCER PRECEPTORSHIP PROGRAMME in Conjunction with Cairo University DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nProf Mohamed Abdallah \nMohamed is the Head of Clinical Oncology department at Kasr Al- Aini Center of Oncology and Nuclear Medicine (NEMROCK)\, Cairo University. \nDr. Mohamed has a special interest and expertise in management of colorectal cancer\, advanced head and neck cancers\, musculoskeletal cancers and genito-urinary cancers. \nDr Primus Ochieng \nPrimus Ochieng is the Programme Director of MMed Radiation Oncology training at the University of Nairobi. He is both a lecturer and a consultant clinical oncologist at Kenyatta National Hospital. \nHe has keen interest in head and neck and prostate cancer treatment. Dr. Ochieng is committed to ensure the program produces well qualified oncologists who will make a difference in cancer treatment in the region. To achieve this\, he is keen in collaborating with various centers in the developed world in areas of training\, research and skill development. \nProf Alaa Meshref \nAlaa Meshref is a Consultant Urologist in multiple institutes and transplant surgeon on Cairo Kidney Center. \nHe has vast experience in prostate cancer diagnosis with over 20\,000 prostate biopsies performed and recently adding cognitive fusion with mpMRI of the prostate across large patient-base patients with BPH and prostate cancer in various stages of the disease. \nProf. Alaa has given more than 20 teaching courses about transrectal ultrasound and prostatic biopsies in conferences and universities. He has presented more than 300 lectures about the early detection of prostate cancer and management of different disease stages \nDr Samuel N. K. Waweru \nSamuel Waweru is a Consulting Urologist at the Nairobi Hospital\, Mater Hospital among others. He is formerly the chair\, Department of Surgery at the Mater Hospital. \nDr Waweru holds a Master’s from the University of Nairobi\, urology training from KCMC Moshi\, Tanzania. \nHis interests are in prostatic cancer and urolithiasis. \nModerator: Dr Tracy Irura  \nTracy Irura is a Senior Registrar in Clinical Oncology at Kenyatta University Teaching\, Research and Referral Hospital. \nShe holds a Master’s in Clinical Oncology and Nuclear Medicine from Alexandria University\, Egypt. \nDr Irura is the co-founder of the Integrated Cancer Research Foundation of Kenya an NGO that seeks to rid Africa of the cancer burden and be a leading cancer research organization in the world.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/prostate-cancer-preceptorship-programme-in-conjunction-with-cairo-university/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/05/prostate-preceptorship.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20221208T190000 DTEND;TZID=Africa/Nairobi:20221208T203000 DTSTAMP:20260423T224351 CREATED:20230524T221310Z LAST-MODIFIED:20230620T115054Z UID:7871-1670526000-1670531400@kesho-kenya.org SUMMARY:Breast cancer preceptorship programme in Conjunction with Cairo University DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Gladwell Kiarie \nGladwell Kiarie graduated with MBChB (Bachelor of Medicine and Bachelor of Surgery) degrees from The University of Nairobi and went head to receive her post-graduate degree in Internal Medicine from the same institution. After receiving her undergraduate degrees\, she did her internship at the Kenyatta National Hospital before proceeding to pursue her fellowship in Medical Oncology in London\, England. \nAfter sub-specialization in Medical Oncology\, she returned to Kenya where she was one of the founding members of the Oncology Unit at the Aga Khan University Hospital and was also part of the team that set up the first Kenyatta National Hospital Tumor Board in 2007 that involved multiple personnel from surgical and medical departments. \nShe then joined the University of Nairobi in the Clinical Medicine Department as a Senior Lecturer. Soon afterwards\, she enrolled in a PhD program with the Bart’s Cancer Institute under the supervision of Professor John Gribben. She recently received Fellowship to the Royal College of Physicians of Edinburgh (FRCPE). \nDr Kiarie currently runs a private practice at The Nairobi Hospital and also reviews patients at other leading hospitals in Nairobi and Nakuru including The Aga Khan University Hospital\, MP Shah Hospital\, and Avenue Hospital. She also serves in the Kenya Medical Practitioners and Dentists Board since her appointment in 2015 to the Regulatory Department of the Board. \nShe is a member of the Kenya Society of Haematology and Oncology (KESHO) where she also served as the treasurer in 2004 and is also a full member of the American Society of Clinical Oncology (ASCO) as well as European Society for Medical Oncology (ESMO). \nShe continues to be an advocate for early diagnosis of cancer and is greatly involved in programs that focus on providing easy access to basic screening services to the under privileged including setting up oncology services at the county level. In recognition of this\, she won the Union for International Cancer Control (UICC) in 2014 for screening in poor settings. \nDr Catherine Nyongesa Watta \nCatherine Nyongesa is a Clinical and Radiation Oncologist at Texas Cancer Centre Nairobi and Kenyatta National Hospital\, with over 20 years of experience in Oncology conducting inpatient and outpatient management of cancer patients. She has a Bachelor’s degree in Medicine and Surgery (University of Nairobi)\, Master of Medicine in Radiation Oncology (University of the Witwatersrand\, South Africa)\, and a Fellowship (FC Rad Onc) in Radiation Oncology from the College of Radiation Oncologists of South Africa. \nAmong the key organizations\, she has been a member of the American Society of Clinical Oncology (ASCO)\, Health Professions Council of South Africa\, International Gynecologic Cancer Society\, and is former Chair of the Kenya Society of Haematology and Oncology (KESHO). \nShe has received a number of awards in recognition of her work nationally and globally. These include: \n\nConquer Cancer Foundation (2011\, ASCO Annual Meeting)\,\nIDEA (International Development Education Award- ASCO\, 2009)\nIGCS (International Gynecologic Cancer Society) Travelling Scholarship Award 2008\nEmployee excellence award KNH 2007\,\nMMED dissertation paper passed with distinction 2005 at University of the Witwatersrand\, SA.\nBest O level and A level student Misikhu Girls High school (St Cecilia)\n\nDr Catherine Nyongesa is the first female radiation oncologist in Kenya. \nShe is one of the founders of the Texas Cancer Center Nairobi\, and currently holds the position of Head of Department of the Cancer Treatment Centre at Kenyatta National Hospital. She is an Honorary Lecturer at the University of Nairobi and the Project/Program Leader of the American Cancer Society (ACS) Patient Navigation Program at Kenyatta National Hospital. She is also the Regional Project Coordinator for the following International Atomic Energy Agency (IAEA)Project: AFRA- RAF/6/055 on Improving the Quality of Radiotherapy in the Treatment of Frequently Occurring Cancers. \nProf Mohsen Mokhtar \nMohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School and Cairo University\, Cairo Egypt. Prof Mokhtar assisted in developing the syllabus and course structure at Al-Kasr Al-Aini\, as well as\, supervised several research programs and theses. \nProf Mokhtar is the managing Director of Cairo University Center of Oncology and Nuclear Medicine NEMROCK and the President of CANSURVIVE. \nProf Mokhtar has published more than 50 articles in several regional magazines in topics including: breast\, lung\, pediatric\, colorectal\, ovarian malignancies NHL and hematologic malignancies. Professionally\, he has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities. \nDr Loay Kassem \nLoay Kassem is an Assistant Professor of Clinical Oncology at Cairo University in Egypt. \nHe had earned his medical degree from Kasr El Eini Medical School – Cairo University in 2005 and MD in Clinical Oncology from Cairo University in 2016. \nDr Kassem is a Research Fellow in Center Léon Bérard\, Lyon\, France. He participated as a Co-investigator in several international clinical trials and has authored several scientific papers in international journals. \nModerator: Dr Thomas Odeny \nThomas Odeny is a Senior Principal Clinical Research Scientist at the Kenya Medical Research Institute and also holds a joint appointment as Assistant Professor of Medicine in the Division of Oncology at the Washington University in St. Louis\, USA. He is Board Certified in Internal Medicine by the American Board of Internal Medicine and completed his Medical Oncology Fellowship at the US National Cancer Institute/National Institutes of Health. \nHe holds an MPH and PhD in Epidemiology from the University of Washington in Seattle\, USA. He is a member of the American Society of Clinical Oncology (ASCO)\, American Society of Hematology (ASH)\, American Association for Cancer Research (AACR)\, and the International AIDS Society. \nHe has authored more than 30 peer-reviewed scientific manuscripts. His research has been published in scientific journals such as ‘Journal of ImmunoTherapy of Cancer’\, ‘Lancet HIV’\, ‘PLOS Medicine’\, ‘BMC Medicine’\, ‘Implementation Science’\, ‘Clinical Infectious Diseases’\, ‘Journal of Acquired Immune Deficiency Syndromes’\, and ‘Journal of the International AIDS Society’ among others. In recognition of his contribution to research and clinical care\, he has received multiple awards including ‘Conquer Cancer Global Oncology Young Investigator Award’\, ‘American Society of Clinical Oncology Merit Award’\, ‘Sirridge Award for Outstanding Humanistic Qualities – University of Missouri’\, ‘Conference on Retroviruses and Opportunistic Infections Young Investigator Award’\, and was the first recipient of the ‘Kenya National AIDS Control Council Young Investigator Award’\, Kenya’s highest award for young scientists in HIV. \nHis career vision in Global Oncology is to address gaps in cancer care by translating research advances to practical and scalable cancer programs in low-resource settings in the U.S. and in Africa through high-quality direct patient care and clinical/translational and implementation research. \nHis clinical research interest is broadly focused on reducing disparities in eligibility for immunotherapy clinical trials and expanding treatment options for cancer in people living with HIV. He is studying the effect of CD4+ T cell count on treatment-emergent adverse events and survival among patients with and without HIV receiving immunotherapy for advanced cancer. This work led to an ASCO Merit Award (2021). \nAs an ASCO Global Oncology Young Investigator Awardee\, Dr. Odeny is also studying the association between Kaposi sarcoma-associated herpesvirus (KSHV) subtypes and clinical severity of disease in patients with KSHV-associated diseases (KAD) in North America and Africa. This will be among the first studies to evaluate KSHV subtype and cytokine profiles as predictors of survival in patients with KAD such as Kaposi sarcoma\, primary effusion lymphoma\, and KSHV-associated multicentric Castleman disease. By integrating patient clinical characteristics with KSHV genomic analyses\, this study will provide a platform for understanding diseases that disproportionately affect low-income\, stigmatized\, and marginalized communities globally\, and are therefore understudied to date. \nHe is also interested in leading patient and clinician education initiatives in global oncology with plans to establish a formal program in Global Oncology between KEMRI and Washington University in St. Louis. This will be a platform for training of a new generation of globally-oriented physicians who will advance scientific discovery for underserved populations with cancer globally. This will be an important step toward sustaining the potential spread of emerging cancer prevention and therapeutic strategies globally and make a lasting impact. \nPrior to pivoting to a career in Global Oncology\, Dr. Odeny was in-country PI or co- investigator for multiple NIH-funded trials\, including 3 NIH R01s. These trials studied the application of implementation science to promote engagement in the HIV care cascade\, and the use of technological innovations to support HIV prevention and treatment efforts. There is a growing recognition that urgent research is needed to find optimal approaches for the translation of efficacious clinical interventions into effective and appropriately scaled programs in the global response to cancer and HIV. As such\, Dr. Odeny is interested in leveraging his expertise in implementation science to the growing academic field of global oncology.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/breast-cancer-preceptorship-programme-in-conjunction-with-cairo-university/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/06/Breast-cancer-preceptorship-scaled.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20221103T190000 DTEND;TZID=Africa/Nairobi:20221103T203000 DTSTAMP:20260423T224351 CREATED:20230601T221136Z LAST-MODIFIED:20230620T115039Z UID:8267-1667502000-1667507400@kesho-kenya.org SUMMARY:Management of Metastatic Non-Small Cell Lung Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Omar Abdihamid \nOmar Abdihamid is a Clinical Oncologist at Garissa Cancer Center and HCGCCK Cancer Centre. \nHe holds a Master’s degree in Clinical Oncology from Central South University\, China. \nHis main areas of interest are Esophageal cancers\, Head and Neck cancers\, Lung cancer\, Genitourinary cancers and Breast cancers. \nDr Omar is passionate about cancer care equity in low- and middle-income countries and advocates for culturally based cancer care. He has a keen interest in Cancer research and has published multiple  publications in international peer-reviewed journals. \nHe is also an a scientific writer\, editor and a reviewer for several cancer journals. \nDr Omar is the recipient of the “2021 Journal of Clinical Oncology\, ASCO Global Oncology Trainee Journal Reviewer Mentoring Program” and the winner of “Africa ASCO VOICES 2022”– for highlighting state of cancer care in Kenya. \nHe is a member of: \n\nKenya Society of Haematology and Oncology (KESHO)\nAfrican Organization for Research and Training in Cancer (AORTIC)\nEuropean Society of Medical Oncology (ESMO)\nAmerican Society of Clinical Oncology (ASCO)\n\nFinally\, Dr. Omar is a resident faculty member and tumour board panelist at the International Cancer Institute in Eldoret\, Kenya. \nModerator: Dr Helena Musau  \nHelena Musau is a Consultant Clinical Oncologist working at Kenyatta University Teaching Research and Referral Hospital. \nShe is also an Adjunct Lecturer at the University of Nairobi\, Radiation Oncology program. Dr. Musau is a Member of various Ministry of Health technical working groups aimed at improving access to cancer care in Kenya. \nDr Musau has worked in both the private and public sectors as well as managed oncology and palliative care projects at various levels over the last 13 years.[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/management-of-metastatic-non-small-cell-lung-cancer/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/06/Metastatic-lung-cancer.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20221020T190000 DTEND;TZID=Africa/Nairobi:20221020T203000 DTSTAMP:20260423T224351 CREATED:20230524T221657Z LAST-MODIFIED:20230602T124918Z UID:7874-1666292400-1666297800@kesho-kenya.org SUMMARY:Optimizing Treatment Outcomes for HR+ and HER2-ve Metastatic Breast Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Amina Kidee \nAmina Kidee is a Medical Oncologist at the Aga Khan University Hospital\, Mombasa. \nHer interests are in breast cancer\, GI malignancy\, and translational research. \nProf Olivia Pagani \nOlivia Pagani was responsible\, at the Institute of Oncology of Southern Switzerland (IOSI)\, for breast cancer medical treatment and clinical research from 2005 to 2019 and of the Clinic for cancer predisposition and high-risk individuals from 2002 to 2019. From 2013 to 2018 she was director of the IOSI Eusoma and Swiss certified Breast Unit and from 2005 to 2008 co-president of the SAKK (Swiss Group for Cancer Research) breast cancer project group. \nShe is the current coordinator of the breast cancer programme of the European School of Oncology and breast cancer consultant at Hopital Riviera-Chablais\, Rennaz\, Vaud. \nIn April 2017 she was nominated Full Professor at the Medical School University of Geneva and in 2019 Full Professor at the Medical School University of Lugano. \nHer main research interests in the last years have been breast cancer in young women and advanced breast cancer. \nShe is panel member of the ESO-ESMO Advanced Breast Cancer (ABC) and chair of the ESO-ESMO Breast Cancer in Young Women Consensus Conferences (BCY). She has been panel member of the San Gallen International Consensus Conference for Early Breast cancer in 2017 and 2019. \nModerator: Dr Siwillis Mithe  \nSiwillis Mithe is a clinical radiation oncologist at the Nakuru County Teaching and Referral Hospital with particular interest in breast\, pediatric\, head and neck and neuro-oncology. She has been key in instituting multidisciplinary meetings within the hospital\, problem-oriented research in the department and streamlining patient care within oncology clinics. \nShe holds a Masters of Medicine in Clinical Oncology and is extensively trained in radiation therapy and chemotherapy for a variety of cancers. \nDr Siwillis has interest in research having attended and presented papers at both local and international conferences and also has a number of publications to her name. She has played a key role in the roll out of National Cancer Screening and Treatment guidelines and has been very instrumental in raising cancer awareness across the country. She is an advocate of quality and affordable cancer care for all patients.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/optimizing-treatment-outcomes-for-hr-and-her2-ve-metastatic-breast-cancer/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/05/metastatic-breast-cancer.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20221013T190000 DTEND;TZID=Africa/Nairobi:20221013T203000 DTSTAMP:20260423T224351 CREATED:20230601T215606Z LAST-MODIFIED:20230602T125452Z UID:8254-1665687600-1665693000@kesho-kenya.org SUMMARY:Genetic Testing For Breast Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Mohammed Ezzi\nMBCHB\, MMed\, FMOnC (UoN) \nMohammed Ezzi is a Lecturer and Consultant Medical Oncologist in the Department of Clinical Medicine and Therapeutics at the University of Nairobi in Nairobi\, Kenya. He is also the Treasurer for the Kenya Society of Hematology and Oncology (KESHO) and also the Chair for the Educational subcommittee in the same Society. \nHe did his Internal Medicine residency at the University of Nairobi and subsequently did a two-year fellowship in Medical Oncology at the same university. He is currently a fellow at the College of the European School of Oncology and pursuing a Certificate in Competence in Breast Cancer by the European School of Oncology. \nHis academic focus is in medical education and is passionate about teaching across the spectrum of medical learners with an interest in enhancing oncologic knowledge amongst non-oncologist. He has presented at several symposia\, workshops and conferences both locally and internationally. He has several publications in peer reviewed international journals. Dr. Mohammed Ezzi is a member of KESHO\, ASCO\, ESMO\, AORTIC and KAP. His key areas of interest include breast cancer\, malignant hematology and clinical pharmacology. \nDr Catherine Mutinda\nMD\, M.MED Pediatrics & Child Health\, MSc. Medical Genetics & Genomics\, DIP. SRHR \nCatherine Mutinda serves as a pediatrician within the Nairobi City County and the National Secretary to the Kenya Pediatrics Association board. She received her medical degree from 1st faculty of Medicine\, Charles University Prague\, the Czech Republic\, a Masters of Medicine in Pediatrics and Child Health from the University of Nairobi\, and a Master of Science in Medical genetics and genomics from the University of Glasgow\, Scotland. \nDr Mutinda has been involved in several operational researches in child health practice. She was involved in setting up the Kangaroo Mother Care and breastmilk bank under one roof at the Pumwani Maternity Hospital\, helping the hospital attain the prerequisites a baby- friendly hospital as envisioned by the WHO. She is a reviewer/committee member at the Scientific and Ethics Review Unit – KEMRI. She committed to growing the practice of genetics in Kenya. \nModerator: Dr Naomi Nyambura Kimani  \nNaomi Kimani is a Clinical Oncologist and Radiation Specialist at Kerugoya County Referral Hospital Cancer Center. \nShe holds a Bachelor`s degree in Medicine and Surgery from Moi University and Master`s degree in Clinical Oncology from Alexandria University\, Egypt. \nShe is a member of Kenya Society of Haematology and Oncology (KESHO)\, African Organization for Research and Training in Cancer (AORTIC)\, and ASCO. \nHer main interests are in management of breast cancer\, gastrointestinal malignancies\, palliative care and radiotherapy.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/genetic-testing-for-breast-cancer/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/06/Genetic-testing-for-breast-cancer.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20221006T080000 DTEND;TZID=Africa/Nairobi:20221006T170000 DTSTAMP:20260423T224351 CREATED:20230524T222202Z LAST-MODIFIED:20230602T125202Z UID:7880-1665043200-1665075600@kesho-kenya.org SUMMARY:Management of Early Breast Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Miriam Mutebi \nMiriam Mutebi is a Consultant Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the Aga Khan University Hospital in Nairobi\, Kenya. She is also a clinical epidemiologist and health systems researcher with a research focus on understanding barriers to access for women with cancers in Sub-Saharan Africa and in designing interventions to mitigate those barriers. \nShe is the President Elect of the African Organization for Research and Training in Cancer (AORTIC)\, the Chairperson for the Kenya Society of Hematology and Oncology (KESHO) and on the board of directors of the Union folr International Cancer Control (UICC).  She is also the co-founder of the Pan African Women’s Association of Surgeons (PAWAS) which was developed to mentor and provide transformative leadership for women in surgery in order to improve surgical care and pathology on the continent and is part of the Kenya Association of Women Surgeons. \nShe is the Co-chair of the National Cancer Taskforce in Kenya\, Chair of the Commonwealth Taskforce for the elimination of Cervical Cancer and a commissioner with three Lancet commissions of Women and cancer\, Cancer in sub-Saharan Africa and Breast Cancer. She is currently pursuing a pilot’s licence in order to extend breast care services to marginalised areas. \nDr Ahmed Komen \nAhmed Komen is a Clinical Radiation Oncologist. He is a fellow of College of Medicine South Africa and holds a Master of Medicine in Radiation Oncology from the University of the Witwatersrand\, Johannesburg\, South Africa. \nHe is a Consultant at Kenyatta National Hospital and a part time faculty member at Aga Khan University Hospital. \nDr. Komen is an active member of various multi-disciplinary tumour boards and the Kenya Society of Haematology and Oncology (KESHO). \nModerator: Dr Mwongeli Matheka  \nMwongeli Matheka is a General Surgeon at Eldoret Regional Hospital. \nShe earned her MBChB from the University of Nairobi and Master of Medicine in General Surgery from Aga Khan University. \nDr Matheka has a special interest in breast surgical oncology and improving access to surgical care in the region.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/management-of-early-breast-cancer/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/05/Management-early-breast-cancer.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20221004T190000 DTEND;TZID=Africa/Nairobi:20221004T203000 DTSTAMP:20260423T224351 CREATED:20230524T221847Z LAST-MODIFIED:20230602T125700Z UID:7876-1664910000-1664915400@kesho-kenya.org SUMMARY:Breast Cancer Policy in Kenya DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Mary Nyangasi \nMary Nyangasi is a medical doctor and global health physician with a 17-year career experience in medical practice\, clinical and preventive oncology\, cancer policy formulation and programming at the Ministry of Health in Kenya. She currently serves as the Head of the National Cancer Control Program and Co-Chair of the National Cancer Taskforce. \nShe is passionate about improving access to care across the cancer care continuum and health system strengthening to ensure delivery of services in a timely\, safe and effective manner. She has led the formulation and implementation of various cancer policy documents and guidelines including the Breast Cancer Screening and Early Diagnosis Action Plan 2021-2025. Globally\, she has also contributed to the drafting of the Global Strategy for Elimination of Cervical Cancer abd the Global Breast Health Initiative. She has interest in cancer research especially in the area of preventive oncology and behavioural studies and have published a number of papers in various peer-reviewed journals. \nDr Nyangasi is a member of the Kenya Medical Association\, the Africa Cancer Coalition\, the Kenya Red Cross and the Kenya Society of Haematology and Oncology. \nDr Daniel Ojuka \nDaniel Ojuka is a Lecturer & Oncoplastic Breast and Endocrine Surgeon\, University of Nairobi & Kenyatta National Hospital. \nHe holds a Bachelor of Medicine and Surgery from the University of Nairobi and Masters of Medicine in Surgery from the same institution. \nDr Ojuka is the current President of the Surgical Society of Kenya. \nModerator: Dr Naftali Busakhala  \nNaftali Busakhala is a senior lecturer and specialist physician at Moi University and Moi Teaching and Referral Hospital. He is the departmental postgraduate coordinator at the department of pharmacology and toxicology at Moi University. He is the co-chairman of the Ampath Oncology working group. Dr Busakhala is the principal investigator of the AIDS Malignancy Consortium\, Moi University Site. He is also the principal investigator of the Lung and Breast Cancer Projects. \nDr Busakhala is a senior research fellow at the Institute of Prevention and Research\, Lyon France. He has published widely in peer reviewed journals. \nHe holds a Bachelor of Medicine and Surgery from Moi University. He holds a Pharmacology Certificate from Tianjin University China. He was a Fogarty trainee in Haematology and Oncology at Brown University\, USA. \nHe trained in Pharmacology and Therapeutics at the Makerere University.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/breast-cancer-policy-in-kenya/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/05/breast-cancer-policy-in-kenya.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220922T190000 DTEND;TZID=Africa/Nairobi:20220922T203000 DTSTAMP:20260423T224351 CREATED:20230524T222031Z LAST-MODIFIED:20230602T130107Z UID:7878-1663873200-1663878600@kesho-kenya.org SUMMARY:CML - Choosing the Next Treatment DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Charles A. Schiffer\, MD \nCharles A. Schiffer\, MD\, is Professor of Medicine and Oncology at Wayne State University School of Medicine and the Karmanos Cancer Institute in Detroit\, Michigan. He is the director of the Leukemia/Lymphoma Multidisciplinary Program. \nDr. Schiffer earned his BA cum laude at Brandeis University and his M.D. at New York University School of Medicine. He completed his internship\, residency\, and chief residency in Internal Medicine at Bellevue Hospital under the auspices of New York University School of Medicine and had subsequent training and positions at the Baltimore Cancer Research Institute\, National Cancer Institute and the University of Maryland School of Medicine\, where he served as Chief of the Division of Hematology. He has also served as Chief of the Division of Hematology/Oncology and Director of Clinical Research at the Karmanos Cancer Institute. \nDr. Schiffer has authored and co-authored more than 300 articles and 80 book chapters on topics concerning the treatment of leukemia in adults\, platelet transfusion\, and granulocyte transfusion therapy\, among others. He has served on the Editorial Boards for Blood\, the Journal of Clinical Oncology\, International Journal of Hematology\, Transfusion Medicine Reviews and Transfusion\, and reviews articles for multiple journals. Committee memberships have included Chairman of the Leukemia Committee of the Cancer and Leukemia Group B\, Chairman of the Food and Drug Administration Oncologic Drug Advisory Committee\, and grant reviews for the NCI and Leukemia/Lymphoma Society of America. Dr. Schiffer has been named among American Health Magazine’s and Castle Connelly’s “Best Doctors in America\,” “Best Cancer Specialists in the US.” In 2006\, he received the Dr. John J. Kenney Award from the Leukemia/Lymphoma Society of America and the Celgene Award for Career Achievement in Hematology. He has received multiple teaching awards from Wayne State University and was recently inducted into the Academy of Scholars\, the highest recognition accorded to academic faculty at the University. \nDr Matilda Ong’ondi \nMatilda Ong’ondi is a Consultant Physician and Clinical Hemato-Oncologist at the Kenyatta National Teaching and Referral Hospital\, Kenya’s oldest and largest hospital. She holds a Bachelor of Medicine and Bachelor of Surgery (MBChB) degree (2005) and a Master of Medicine (MMed) degree in Internal Medicine (2010)\, both from the University of Nairobi. She is registered with the Kenya Medical Practitioners and Dentists Council as an Internal Medicine Specialist. \nDr. Matilda pursued her Clinical Hemato-oncology training at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital\, Australia in 2017. In addition\, she has undertaken various short Fellowship opportunities through the following institutions: International Chronic Myeloid Leukemia Foundation (Royal Adelaide Hospital and SAHMRI Adelaide\, 2017); American Society of Hematology\, Visitor Training Program at The Cancer Therapy and Research Centre\, San Antonio Texas (2014); and Mayo Clinic\, Rochester\, Minnesota (2010). \nHer main interests are: Multiple Myeloma; Acute Leukemia; Chronic Leukemia; and Platelet disorders. Her other interests are Psycho-Oncology and Clinical Research. She is also passionate about clinical bedside teaching and mentorship. \nDr. Matilda is a member of various societies: Kenya Society of Hematologists and Oncologists (KESHO); European Hematology Association (EHA); and International Society of Thrombosis and Hemostasis (ISTH). In addition\, she served as a member of the bodies that developed the Kenya National Cancer Guidelines and NCCN Harmonized Guidelines. \nModerator: Dr Angela McLigeyo  \nAngela McLigeyo is a licensed Physician and Medical Oncologist practicing in Kenya. She has a Master of Medicine in Internal Medicine from the University of Nairobi\, a M.Sc. in Clinical Oncology from Ulm University (Germany)\, and a Fellowship in Medical Oncology from the University of Nairobi. In addition\, she obtained a 5-year board certification in Medical Oncology from ESMO in 2019. She has over 17 years of experiences in hospital and clinical settings. \nShe is a member of the Kenya Society of Haematology and Oncology (KESHO)\, European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). She is also a fellow of the East\, Central and Southern Africa College of Physicians. \nHer core skills are in clinical decision making in internal medicine and oncology\, conducting trainings\, streamlining medical education and conducting research as well as participation in the development of treatment guidelines and protocols. \nDr McLigeyo currently provides comprehensive oncology healthcare at both public and private health facilities\, conducts research in oncology and internal medicine when opportunities arise\, and is engaged in teaching internal medicine and oncology at the Kenyatta University. She has authored several research articles in peer reviewed journals and presented abstracts at several conferences.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/cml-choosing-the-next-treatment/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/05/CML.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220915T194500 DTEND;TZID=Africa/Nairobi:20220915T204500 DTSTAMP:20260423T224351 CREATED:20230524T222622Z LAST-MODIFIED:20230602T130342Z UID:7886-1663271100-1663274700@kesho-kenya.org SUMMARY:Prostate Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nProf Mack Roach \nProfessor Mack Roach III\, MD\, is a Professor of Radiation Oncology\, Medical Oncology and Urology\, at the University of California\, San Francisco. Roach earned his MD from Stanford University School of Medicine. His major research interest involves the application of 3-D conformal and intensity modulated radiotherapy (IMRT) treatment planning technology as a major component of combined modality management of prostate cancer and other solid tumors. Over the last 10 years\, his research efforts have been directed at defining optimal imaging modalities\, as well as criteria for defining target volumes and improved treatment techniques. \nProf Roach chaired one of the most important large prospective randomized trials comparing different strategies for locally advanced prostate cancer. He has gained international recognition as an authority on treatment planning for prostate cancer and served as senior author for the guidelines for treatment planning recently published by the American College of Radiology. \nProf Roach is a member of several professional societies including the American Society of Clinical Oncology\, American Society for Therapeutic Radiology and Oncology\, Radiation Therapy Oncology Group\, the NCI IMRT Working Group and American Joint Commission for Cancer (AJCC) Staging (GU)\, the American Cancer Society (ACS) Task for Cancer Screening Guidelines (Prostate cancer) and the NCI Concept Evaluation Panel (Prostate Cancer Phase III Trials). \nProf Silke Gillessen\nProfessor Silke Gillessen is a Medical Oncologist with focus on genitourinary cancer. \nShe completed her training in Basel\, St. Gallen\, and the Dana Farber Cancer Institute\, Boston. After returning to Switzerland\, she built up the medical oncology unit for genitourinary cancer and headed the clinical research unit for oncology/haematology in Cantonal Hospital\, St Gallen. \nShe served for two terms as president of the SAKK GU group\, she chaired the EORTC Genitourinary Cancers Group\, and has founded the Advanced Prostate Cancer Consensus Conference (APCCC). \nSince 2018\, Prof Gillessen has been Genitourinary Cancer Systemic Therapy Research Chair at the University of Manchester and Honorary Consultant at The Christie Hospital\, while continuing to work as Consultant in the Department of Oncology/Haematology at the Kantonsspital St. Gallen\, Switzerland. \nIn January 2020 Prof Gillessen was appointed Head of the Department of Medical Oncology\, full professor at the Università della Svizzera Italiana (USI) in Lugano and Director of the Oncology Institute of Southern Switzerland (IOSI) in Bellinzona\, Switzerland. \nDr Samuel Nguku\nDr Samuel Nguku is a Consultant in Radiology and Nuclear Medicine at Aga Khan University Hospital Nairobi. \nHe has a master’s degree in Radiology from Aga Khan University and fellowship in Nuclear medicine from Imperial College London. \nDr Nguku was integral in setting up of the first PET CT service in Kenya at the Aga Khan University Hospital Nairobi. \nHe has great passion in improving cancer imaging in the country and integrating molecular imaging in management of cancer patients. \nModerator: Dr Angela Waweru \nDr Angela Waweru is a Consultant Clinical Oncologist and Section Head of Radiation Oncology at Aga Khan University Hospital\, Nairobi. \nShe graduated from the University of Sheffield and undertook her Core Medical and Clinical Oncology training in Sheffield Teaching Hospitals NHS Trust where she received her certificate of completion of training in 2015 and thereafter took on a Consultant Clinical Oncologist position within the same trust. \nShe is passionate about increased uptake of advanced radiation technological advances that achieve better outcomes and less toxicity. She has been instrumental at starting advanced radiation services at a leading health care facility in Nairobi. She has also promoted public private partnerships within radiation oncology and in 2022 started a pathway for treating patients requiring more conformal techniques of treatment not readily available at their institutions. \nDr Waweru is keen on promoting radiotherapy governance\, she has started radiotherapy safety committees\, peer review meetings and service development projects that benchmark local activities against standard guidelines. \nShe is a Fellow of the Royal College of Radiologist (Clinical Oncology faculty)\, Member of the Royal College of Physicians and Kenya Society of Haematology and Oncology.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/prostate-cancer-4/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/05/prostate-cancer-15-sept.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220908T190000 DTEND;TZID=Africa/Nairobi:20220908T203000 DTSTAMP:20260423T224351 CREATED:20220805T120410Z LAST-MODIFIED:20230602T130741Z UID:7792-1662663600-1662669000@kesho-kenya.org SUMMARY:Childhood Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr\, S. P. Yadav \nDr Yadav is currently working as the Director of Pediatric Hemato Oncology & Bone Marrow Transplant at Medanta Hospital Gurugram India. He holds a Bachelor of Medicine and Surgery from University College of Medical Sciences. He has a Diploma in Child Health from Maulana Azad Medical College\, D.N.B (Pediatrics) from Sir Ganga Ram Hospital\, Delhi. Fellow in Pediatric Hemato-Oncology\, Royal Alexander Hospital for Children\, Westmead Australia \nHis clinical focus is primarily Pediatric Leukemia and Bone Marrow transplantation. He has a goal to make BMT available and affordable to all those who need it. With a rich experience of more than 24 years he has performed over 400 blood & marrow transplants including 50 unrelated donor/cord transplant and 50 Haplo identical bone marrow transplants. \nDr Yadav is an accomplished editor on Oncopedia\, and has worked on the editorial front for cure4kids\, St. Jude’s Hospital USA\, he has also been endowed with ANZCCSG scholarship and he presented a paper during SIOP meeting in Brisbane. He successfully worked as the national co-coordinator on National Training Program in Practical Pediatric Hematology (NTPPPH)\, and as a secretary for Organ Transplant Group\, Indian Academy of Pediatrics. He was awarded with the prestigious Dr CK Bhalla Award in the year 2002 \nHis areas of interest include pediatric leukemia\, pediatric blood disorders\, pediatric oncology\, and blood & marrow transplantation. \nDr Yadav is a member of: \n·       American Society of Hematology (ASH)\n·       American Society of Clinical Oncology (ASCO)\n·       International Society of Pediatric Oncology (SIOP)\n·       Pediatric Hemato-Oncology (PHO)\n·       Chapter of Indian Academy of Pediatrics (IAP) \nDr Yadav has published widely in national and international journals. \nDr Deborah Omeddo\nDr. Deborah Omeddo is a Paediatric Haematologist and Oncologist working in Kisii Teaching and Referral Hospital. \nShe holds a Master’s in Paediatrics and Child Health from the University of Nairobi. She did her fellowship training at Makerere University. \nDr Omeddo strives to provide quality health services to children living with cancer and blood diseases. Her vision is that all children in Kenya will have access to quality healthcare services regardless of location and socio-economic status. \nModerator: Dr Irene Nzamu  \nDr Irene Nzamu is a Pediatric Hematologist Oncologist and Head\, Pediatric Hemato Oncology Unit\, Kenyatta National Hospital. \nShe completed her undergraduate training (MBChB) and postgraduate training (M.MED) at University of Nairobi. She did her Fellowship in Pediatric Hematology and Oncology at Makerere University in collaboration with Baylor College of Medicine & Global HOPE Texas Children’s Hospital. \nDr Nzamu is passionate about offering evidence based\, affordable care for children with cancer & blood diseases in our resource limited settings.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/childhood-cancer-2/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/08/childhood-cancers.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220901T190000 DTEND;TZID=Africa/Nairobi:20220901T203000 DTSTAMP:20260423T224351 CREATED:20230524T222304Z LAST-MODIFIED:20230602T131157Z UID:7884-1662058800-1662064200@kesho-kenya.org SUMMARY:Conducting Cancer Clinical Trials In East Africa Are We Ready? DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nProfessor Mansoor Saleh   \nMansoor Saleh\, MD received his early education in the Aga Khan School system in East Africa\, his medical education at the University of Heidelberg in Germany and conducted his doctoral research at the Max Planck Institute for Medical Research in Heidelberg. He received his training in internal medicine at the Henry Ford Hospital in Detroit Michigan and clinical and translational research training in Hematology & Oncology at the University of Alabama Comprehensive Cancer Center in Birmingham\, Alabama where he was tenured Professor of Medicine & Pathology and Director of the First-in-Human Early Drug Development Program. \nHis area of research and clinical focus is “targeted therapy of cancer”. In January 2020\, he joined the Aga Khan University in Nairobi\, Kenya as the Founding Chair\, Department of Hematology – Oncology and Founding Director – AKU\, N Cancer Center. \nModerator: Dr Sitna Mwanzi  \nSitna Ali Mwanzi is a consultant medical oncologist working at the Kenyatta National Hospital in Nairobi Kenya. She obtained her Bachelor of Medicine and Surgery from the University of Nairobi and Master of Medicine in Internal Medicine from the Aga Khan University Hospital\, Nairobi. She undertook a fellowship in Medical Oncology at Barts Health NHS Trust in the United Kingdom attaining a Specialist Certificate in Medical Oncology from the Royal College of Physicians and Association of Cancer Physicians in the United Kingdom. She also has a Master of Science in Advanced Oncology from Ulm University in Germany. \nHer research interests include breast cancer\, lung cancer\, prostate cancer\, chronic myeloid leukemia and cervical cancer. She is passionate about increasing health care workers and general public awareness about cancer\, role of screening\, early diagnosis and treatment of cancer. She works closely with the National Cancer Control Program in implementation of the National Cancer Control Strategy and advising on cancer policy for improving access to cancer care.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/cancer-clinical-trials/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/05/unnamed-15.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220825T190000 DTEND;TZID=Africa/Nairobi:20220825T203000 DTSTAMP:20260423T224351 CREATED:20230524T222924Z LAST-MODIFIED:20230602T131708Z UID:7891-1661454000-1661459400@kesho-kenya.org SUMMARY:Prostate Cancer: Active surveillance in Prostate Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Njoki Njiraini  \nDr Njiraini is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in The Nairobi Hospital. \nShe has been key in instituting multidisciplinary meetings\, problem oriented research in the department\, and streamlining patient care within the oncology clinics in the public and private sector. \nDr Njiraini holds a bachelor’s degree in Medicine and Surgery from the University of Nairobi\, a Master’s Degree in Radiation Oncology from the University of Cape Town\, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and  a graduate of the Harvard POETIC Fellowship programme. \nDr David K. Kimani\nMBChB\, MMed General Surgery UON (2007) \nDr. Kimani is a Consultant Urologist at Kenyatta National Hospital in Kenya\, and an Honorary Lecturer in the Department of Surgery at the University of Nairobi. He did his Clinical Fellowship in Urology at the Global Health Institute Chennai\, India in 2014. He has keen interests in Prostate Care and Kidney Transplantation. \nDr. Kimani is a Member of the Surgical Society of Kenya (SSK)\, Kenya Association of Urological Surgeons (KAUS)\, Society for International Urologists\, (SIU)\, and the American Urological Association (AUA). \nModerator: Dr Regina Nanzia Ojiwa \nRegina Nanzia Ojiwa is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in Kenyatta National Hospital. \nShe holds a Bachelor’s degree in Medicine and Surgery from Moi University and a Master’s degree in Clinical Oncology and Nuclear Medicine from Alexandria University\, Egypt. \nDr Nanzia has key interest in Esophageal\, Colorectal and Prostate cancer.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/prostate-cancer-5/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/05/prostate-cancer.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220818T190000 DTEND;TZID=Africa/Nairobi:20220818T203000 DTSTAMP:20260423T224351 CREATED:20230601T213044Z LAST-MODIFIED:20230602T131940Z UID:8238-1660849200-1660854600@kesho-kenya.org SUMMARY:Unique presentations of Malignant Lymphoma DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Andrew Odhiambo  \nMBChB\, MMed(Int.Med)\, MedOnc(UK)\, FRCP Edin\, FCP (ECSA)\nConsultant Physician & Medical Oncologist – Prime CancerCare Clinic Nairobi.\nThematic Unit Head – Medical Oncology & Lecturer University of Nairobi (UON) \nAndrew Odhiambo is a board certified Consultant Physician & Medical Oncologist at the Prime CancerCare Clinic – Nairobi. He is the Unit Head for Medical Oncology at the University of Nairobi (UON). Dr. Andrew holds a Master’s degree in Internal Medicine from the UON. He later did his Fellowship in Medical Oncology in the United Kingdom and is certified by the Federation of Royal College of Physicians of the United Kingdom (RCP-UK)\, The Association of Cancer Physicians (ACP) and the European Society for Medical Oncology (ESMO). He is a Fellow of  the Royal College of Physicians of Edinburgh as well as the East\, Central & Southern Africa College of Physicians. \nHe is the outgoing Secretary & former treasurer of Kenya Society of Haematology & Oncology (KESHO). Dr Andrew is a member ASCO\, ESMO & AORTIC. He serves as an expert advisor for local and international bodies i.e. MOH\, Kenya Cancer Prevention TWG\, various international Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals. Dr Andrew has attended over 50 oncology meetings both local and international. He has made over 40 oral presentations and continuously supports Oncology Multidisciplinary team meetings in various top hospitals in Nairobi. \nDr Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 60 appearances in mainstream local and international TV\, Radio and print media promoting cancer awareness. Key areas of sub-specialization and interest include Gastrointestinal cancers\, Pancreatic\, Liver  & Bile Duct cancer\, Metastatic Breast Cancer\, Lymphoma\, Cancer of Unknown Primary as well as newer treatments i.e. Immunotherapy & Targeted therapy. \nFor his full profile\, please visit www.drandrewodhiambo.com \nModerator: Dr Kevin Makori \nKevin Makori is a Clinical Oncologist at the International Cancer Institute Care and Research Clinic (ICI-CRC)\, Eldoret Kenya. He is involved in cancer patient care and several ongoing immunooncology and haematology clinical trials as a sub investigator at ICI\, under the mentorship of his PI and Director\, Prof Chite Asirwa. He also heads the Education and Training Office at the Institute\, and is involved in teaching and coordination of various oncology capacity building activities. Dr Makori is also a visiting Clinical Oncologist at Tenwek Hospital and a member of the Hospital’s oncology multidisciplinary team. \nHe received his postgraduate training (MMed Clinical Oncology) at Muhimbili University of Health & Allied Sciences\, a program domiciled at Tanzania’s national oncology referral centre\, Ocean Road Cancer Institute\, Dar es Salaam. \nDr Makori is a member of the Kenya Society of Haematology and Oncology (KESHO)\, a Global LMIC Associate (Non-Training) Member of the Royal College of Radiologists (RCR) and ASCO. He is a Junior Associate Editor of the RCR’s Clinical Oncology Journal and a current beneficiary of the Journal’s Junior Assistant Editor Mentorship Programme. \nHis key professional interests are in radiation sciences\, immuno-oncology\, clinical trials and oncology education.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/unique-presentations-of-malignant-lymphoma/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2023/06/malignant-lymphoma.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220811T190000 DTEND;TZID=Africa/Nairobi:20220811T203000 DTSTAMP:20260423T224351 CREATED:20220719T044051Z LAST-MODIFIED:20230602T132220Z UID:7762-1660244400-1660249800@kesho-kenya.org SUMMARY:Liver Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nProf Mohamed Farouk Mostafa\nMohamed Farouk graduated from Alexandria Medical School in 1992. \nProf. Farouk joined the Alexandria Clinical Oncology Department ACOD in 1994\, starting the journey from resident till becoming Professor of Clinical Oncology in the year 2018. \nProf Farouk has more than 30 publications in the field of oncology; some of them published in level A journals. He participated as a co-investigator in the grant from STDF\, Egypt. He has attended several advisory boards for different Pharma companies. \nHis areas of interest include GIT malignancy\, breast and Gynaecology cancer. \nDr Mercy Gatua\nMercy Gatua is a Medical Oncologist at the Kenyatta University Teaching Research and Referral Hospital. She received her Medical Oncology Fellowship from the University of Nairobi in 2019. Prior to that\, she earned her MMED in Internal Medicine at the same university (UON). \nHer main interests are in the management of acute leukemia’s\, GI malignancies and Cervical Cancer. She also has an interest in research geared to understanding the genetic basis of cancer. \nModerator: Dr Abeid Athman \nAbeid Omar is a consultant Clinical (medical and radiation) Oncologist and Nuclear Medicine based in Kilifi\, Kenya. Besides\, he consults for International Cancer Institute – ICI Eldoret\, Kenya. He has keen interest in breast cancer in young women\, oncofertility\, breast cancer research\, radiotherapy\, advocacy and Global Oncology particularly in LMIC. \nDr. Abeid completed his training in Clinical Oncology and Nuclear Medicine in Alexandria University Egypt in 2021. He is a fellow of College of European School of Oncology (ESCO) and he has also successfully passed the ESMO exam to become a certified ESMO oncologist. \nDr. Abeid has conducted researches\, presented abstracts in ESMO\, ASCO\, ESTRO\, St. Gallen\, KESHO conferences and Aga Khan Symposium\, published in peer reviewed journals about breast cancer in young women\, pregnancy associated breast cancer\, pregnancy after breast cancer among others under the close guidance of Prof. Hatem Azim\, who has been mentoring him since 2019. \nDr. Abeid is an active member of several societies including KESHO – where he also serves as a member of the education committee\, ASCO\, ESMO\, ESCO\, Society of Toxicology. In 2019 he was awarded the ASCO Virtual Mentorship Program and currently he is under the mentorship of College of European School of Oncology. Besides\, Dr. Abeid serves as a reviewer for several journals.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/liver-cancer-2/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/07/liver-cancer.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220804T190000 DTEND;TZID=Africa/Nairobi:20220804T203000 DTSTAMP:20260423T224351 CREATED:20220719T043911Z LAST-MODIFIED:20220803T110534Z UID:7760-1659639600-1659645000@kesho-kenya.org SUMMARY:Haematology DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES \nDr Laura Kirui\nMBChB BSc FRCP Edin FRCPath \nDr. Laura Kirui is a Consultant Haematologist\, in the Department of Haematology-Oncology at Aga Khan University Hospital Nairobi. \nAlongside her work in malignant haematology she has a special interest in haemostasis and thrombosis and obstetric haematology. In her role as Clinical Lead for haemostasis and thrombosis she is working to expand this service at AKUHN with new dedicated clinics\, guidelines and expanded laboratory testing.\nPrior to this Dr Kirui was a Consultant Haematologist/ Haemato-oncologist at the North Middlesex University Hospital\, UK working in malignant and benign haematology and heading the Transfusion and Haematology laboratory. \nDr. Kirui underwent specialist training in Haematology at University College London Hospital where she received her Certificate of Completion of Training. \nShe is a Fellow of the Royal College of Pathologist\, UK and a Fellow of the Royal College of Physicians and has a Bachelor’s of Medicine and Surgery from the University of Leeds\, UK with an intercalated BSc in International Health. \nModerator: Dr Anne Mwirigi\nMBChB\, MRCP\, FRCPath (UK)  \nDr Mwirigi is a consultant haematologist working at the Aga Khan University Hospital in Nairobi\, Kenya. She obtained her undergraduate MBChB from the University of Glasgow in 2002. After her house jobs and a medical rotation in Glasgow\, she moved to London in February 2007. \nHer career in Haematology began as a senior house officer at King’s College Hospital\, following which she was accepted on the Guy’s and St Thomas’ NHS Trust Specialist Registrar Rotation in 2009. She obtained her certificate of completion of training in 2014\, and thereafter took on consultant haematologist positions for a period of two and a half years at both Guy’s and St Thomas’ and King’s College Hospitals. \nDr Mwirigi has a passion for haematology and always planned to practice haematology in her country of birth\, Kenya. Since moving back in December 2016\, she has engaged with haematopathologists and clinical haematologists in the region\, and is involved collaborative ventures aimed at improving the quality of haematology services in Kenya. She was a key member of the scientific committee which organised the Haematology and Oncology Society of Africa 3rd inaugural conference held in Nairobi in August 2017. \n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n REGISTER \n [/vc_column][/vc_row] URL:https://kesho-kenya.org/event/haematology/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/07/unnamed.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220728T180000 DTEND;TZID=Africa/Nairobi:20220728T210000 DTSTAMP:20260423T224351 CREATED:20220524T074918Z LAST-MODIFIED:20220801T104207Z UID:7654-1659031200-1659042000@kesho-kenya.org SUMMARY:East African Colorectal Cancer Summit DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES:\nDR ANDREW ODHIAMBO\nMBChB\, MMed(Int.Med)\, MedOnc(UK)\, FRCP Edin\, FCP (ECSA) \nAndrew Odhiambo is a board certified Consultant Physician & Medical Oncologist at the Prime CancerCare Clinic – Nairobi. He is the Unit Head for Medical Oncology at the University of Nairobi (UON). Dr. Andrew holds a Master’s degree in Internal Medicine from the UON. He later did his Fellowship in Medical Oncology in the United Kingdom and is certified by the Federation of Royal College of Physicians of the United Kingdom (RCP-UK)\, The Association of Cancer Physicians (ACP) and the European Society for Medical Oncology (ESMO). He is a Fellow of  the Royal College of Physicians of Edinburgh as well as the East\, Central & Southern Africa College of Physicians. \nHe is the former Secretary and Treasurer of Kenya Society of Haematology & Oncology (KESHO). Dr Andrew is a member ASCO\, ESMO & AORTIC. He serves as an expert advisor for local and international bodies i.e. MOH\, Kenya Cancer Prevention TWG\, and various international Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals. Dr Andrew has attended over 50 oncology meetings both local and international. He has made over 40 oral presentations and continuously supports Oncology Multidisciplinary team meetings in various top hospitals in Nairobi. \nDr Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 60 appearances in mainstream local and international TV\, Radio and print media promoting cancer awareness. Key areas of sub-specialization and interest include Gastrointestinal cancers\, Pancreatic\, Liver  & Bile Duct cancer\, Metastatic Breast Cancer\, Lymphoma\, Cancer of Unknown Primary as well as newer treatments i.e. Immunotherapy & Targeted therapy. \nFor his full profile\, please visit www.drandrewodhiambo.com \nDR JERRY NDUMBALO\nMD MMED Onc (SA) MBA \nJerry Ndumbalo is a Consultant Clinical and Radiation oncologist\, Lecturer\, and Researcher at Ocean Road Cancer Institute and MUHAS with over 15 years of clinical experience and is currently the Founder and First President of the Tanzania Oncology Society (TOS). \nDr Ndumbalo is a holder of a Doctor of Medicine degree from the University of Dar es Salaam in 2006\, Masters of Medicine (MMED) in Radiation and Clinical Oncology from the University of Witwatersrand\, South Africa\, in 2016\, and a Masters of Business Administration (MBA-General Management) from the University of Dar es Salaam\, Tanzania\, in June 2022. \nWith vast research interests in clinical research and global health\, he has published over 15 articles in peer-reviewed international journals. He is currently serving as a Principal and Co-investigator on numerous projects\, including Guideline development and implementation studies\, Cervical Cancer and HIV (BMSF)\, Automated Contouring and Planning (AROMA-C)\, and Breast CHARTA study. \nHe has actively participated in and led several technical working groups\, including the African Cancer Coalition (ACC)\, which partners with NCCN in developing Harmonised Cancer Treatment Guidelines for Sub-Saharan Africa. In this Coalition\, he chaired the cervical cancer working group. He was a member in developing NCCN harmonized treatment guidelines for Esophageal\, Gastric\, Colorectal\, Ovarian\, Prostate\, ALL\, and AML. He also chaired the technical work to establish the 1st Tanzania National Cancer Treatment Guidelines in 2020. To ensure its utilization\, he led ORCI/UCSF team to develop implementation strategies to increase the guideline uptake in Tanzania. He is a reviewing committee member for the Standard Treatment Guidelines (STG) and National Essential Medicines List for Tanzania. \nDr. Ndumbalo is a member of the American Society of Clinical Oncology (ASCO) and was recently awarded International Development and Education Award (IDEA 2022). He is a member of the Africa Organisation for Research and Training in Cancer (AORTIC)\, serving on its Research Committee in 2020/2021. He also holds membership in the European Society of Medical Oncology (ESMO)\, the American Society of Radiation Oncology (ASTRO)\, and the American Association for Cancer Research (AACR). He is a board member of the Tanzania Non-Communicable Diseases Association (TNCDA). \nDR FRED OKUKU\nMBChB (MUK)\, MMED (MUK)\, HAMPT (UW\, USA)\, FCP (ESACOP) \nFred Okuku is a Consultant Physician/Medical Oncologist and the current Head of the Solid Tumor and Private Patient Services\, at the Uganda Cancer Institute (UCI). He is a Research Investigator with the Hutchinson Cancer Research Institute-Uganda in Kampala and a Co-PI on the AMC 098 NCI-NIH\, a Nelfinavir clinical trial in Kaposi Sarcoma patients at the UCI. \nDr Okuku is a Research Investigator with John Hopkins Program on Liver Cancer in Uganda. He is also a co-investigator on the U54 Lung cancer – HIV study a collaboration between Makerere University and Case Western University (CWRU)\, Cleveland and a local PI of a phase III\, randomized\, open-label\, multicenter study evaluating the efficacy and safety of adjuvant giredestrant compared with physician’s choice of adjuvant endocrine monotherapy in patients with estrogen receptor-positive\, HER-2‑negative early breast cancer. \nDr Okuku has accomplished a number of research projects both locally and collaboratively. \nDR NJOKI NJIRAINI (MODERATOR) \nNjoki Njiraini is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in The Nairobi Hospital. \nShe has been key in instituting multidisciplinary meetings\, problem oriented research in the department\, and streamlining patient care within the oncology clinics in the public and private sector. \nDr Njiraini holds a Bachelor’s degree in Medicine and Surgery from the University of Nairobi\, a Master’s Degree in Radiation Oncology from the University of Cape Town\, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and  a graduate of the Harvard POETIC Fellowship programme. \n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/metastatic-colorectal-cancer-2/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/05/KCUyqj88.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220714T190000 DTEND;TZID=Africa/Nairobi:20220714T203000 DTSTAMP:20260423T224351 CREATED:20220623T111540Z LAST-MODIFIED:20220719T044439Z UID:7731-1657825200-1657830600@kesho-kenya.org SUMMARY:Gastric Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Manel Haj Mansour\nManel Mansour is a Consultant Physician and board certified Medical Oncologist currently working at the Aga Khan University Hospital. She was formerly a consultant medical oncologist at Texas Cancer Centre\, Nairobi and also worked as a consultant medical oncologist and a lecturer at Abderrahmen University Hospital\, Tunisia. \nDr. Mansour graduated from the Faculty of Medicine of Tunis in 2012 and completed medical oncology residency in 2017.\nShe holds: \n\nA certificate of completion of Oncologic Science Course on line in Breast Cancer Treatments from The Africa Breast University.\nA certificate of medical oncology training on XXXIIth course antitumor chemotherapy and cancer medical treatment at Gustave Roussy Institute Paris\, France.\nA post graduate certificate in Prevention and Palliative Care in Oncology\, Faculty of Medicine of Sousse.\nA post graduate certificate in Thoracic Oncology\, Faculty of Medicine of Tunis.\nA post graduate certificate in Breast Disease\, Faculty of Medicine of Tunis.\n\nShe is a member of ESMO\, ASCO\, STOM (Tunisian Society of Medical Oncology) and KESHO. Her areas of interest include breast cancer\, lung cancer\, gastrointestinal cancers\, gynecological and genitourinary cancers. \nDr Abdi Hakin Mohamed\nMD\, M.Med\, FCS (ECSA) \nAbdi Hakin Mohamed is a Surgical Oncologist and Consultant Laparoscopic Surgeon based in Mombasa. \nHe did his Surgical Residency at the Aga Khan Hospital\, Nairobi and Surgical Oncology Fellowship at the prestigious Memorial Sloan- Kettering Cancer Centre in New York\, USA where he was the first ever Clinical Fellow from the African continent. At Memorial Sloan Kettering\, he worked with world-renowned colorectal surgeons and was involved in research projects in the institution as well as operating on patients using the most highly advanced surgical equipment\, including Robotic Colorectal Surgery for colon and rectal cancer. Dr Abdi has been part of local colorectal cancer trials with his mentor the late Prof Saidi Hassan\, and has published the most widely quoted colorectal cancer study in East Africa. \nDr Abdi works both in the private sector and public sector. He is the Chair of Surgery at the Aga Khan Hospital in Mombasa\, and is currently involved in treating cancer patients who need surgery in Mombasa. He is the coordinator of the fellowship division of the COSECSA (College of Surgeons of East\, Central and Southern Africa) surgical training program at Coast General Teaching and Research Hospital which is the largest COSECSA program in East Africa. \nModerator: Dr Irene Weru \nIrene Weru has worked at Kenyatta National Hospital since 2003 and is current Head of Pharmaceutical Products. She holds a master’s degree in Clinical Pharmacy with sub-specialization in oncology pharmacy from the University of Nairobi. \nDr. Weru is a member of various National and international technical working groups including Demand Forecasting and Quantification TWG of the Coalition for Access to NCD Medicines\, ChemoSafe Regional TWG\, Pharmacy Advisory Council -Global HOPE Pediatric Hematology /Oncology Centers of Excellence and NCI-Kenya Quality Management Expert Working Group. \nDr. Weru is a member of several professional associations including HOPAK\, PSK\, KESHO and ISOPP. She is the current Secretary to the International Society of Oncology Pharmacy Practitioners (ISOPP). \nBesides oncology\, Dr. Weru has interest in medicines management and use especially medicine formulary management. She is also an honorary lecturer at University of Nairobi\, School of Pharmacy and provides research and clinical practice supervision to undergraduate and postgraduate students.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/gastric-cancer/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/06/unnamed-9.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220707T190000 DTEND;TZID=Africa/Nairobi:20220707T203000 DTSTAMP:20260423T224351 CREATED:20220623T111428Z LAST-MODIFIED:20220719T044648Z UID:7729-1657220400-1657225800@kesho-kenya.org SUMMARY:Palliative Care DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Christian Ntizimira\nChristian Ntizimira is the Founder/Executive Director of the African Center for Research on End-of-Life Care (ACREOL)\, a non-profit organization to bring socio-cultural equality through “Ubuntu in End-of-life Care” in Africa. \nHe is a Fulbright Alumni and graduated from Harvard Medical School\, department of Global Health and Social Medicine.  Dr Ntizimira is the winner of the prestigious Tällberg-Stervos Niarcos Foundation-Eliasson Global Leadership Prize 2021\, for his passionate advocacy for palliative care in Rwanda and elsewhere in Africa\, based on his deeply held belief that dignified end-of-life care is a human right. \nHe pioneered integration of palliative care and end of life care into health services rendered to Rwandan cancer patients and in the community settings.  Through his leadership more than 1500 health care providers and community health workers have learned the principles of cancer prevention control & palliative care leading to a five-fold increase in prescription of morphine\, an essential pain medication. In 2016 Dr Ntizimira was awarded as a young cancer leader and world cancer Regional\, lead in 2018 for his outstanding contributions in cancer control in Rwanda and in Africa. \nHe was a member of the scientific Advisory Committee for the Lancet Commission on Global Access to Palliative Care and Pain Control published in 2018 and commissioner for the Lancet Oncology Commission on Cancer in Sub-Saharan Africa published in 2022. In 2018 he became the first advocacy/policy champion among extraordinary individuals who are making a significant contribution to developing palliative care in low- and middle-income countries for World Hospice and Palliative Care Alliance (WHPCA). From 2010–13\, he was the director of Kibagabaga Hospital in Kigali. \nMackuline Atieno\nExecutive Director\, Kenya Hospices and Palliative Care Association (KEHPCA) \nMackuline is a Palliative Care Nurse and Medical Anthropologist with over 12 years’ experience in palliative care development. She is passionate about improving health outcomes through research and evidence based practice; and use of technology. \nBefore Joining KEHPCA\, Mackuline worked with the African Palliative Care Association. She has provided technical support and management for more than 10 multi-partnership and multi-country projects in African countries including Botswana\, Eswatini\, Ghana\, Malawi\, Mozambique\, Namibia\, Rwanda\, South Africa\, Uganda\, Zambia\, Zimbabwe as well as Kenya. \nShe has been involved in palliative care policy reviews and development\, research and development of palliative care information\, education and communication materials and e learning at national and regional levels. \nMackuline holds a Bachelor’s Degree in Nursing\, Diploma in Palliative Care\, and is completing a Masters in Medical Anthropology. \nModerator: Dr Zipporah Ali \nMD\, MPH\, MPC\, HonDUniv\nChair of Non-Communicable Diseases Alliance Kenya\nTechnical Advisor/Consultant/Researcher  \nZipporah Ali has recently retired from the position of Executive Director of Kenya Hospices and Palliative Care Association (KEHPCA)\, a position she held for 15 years.  She serves on the board of several organizations including; Kenya Hospices and Palliative Care Association\, International Children’s Palliative Care Network (ICPCN)\, City Cancer Challenge\, Alzheimer/Dementia Kenya\, Public Health and Palliative Care International and Kenya Network of Cancer Organizations (KENCO). She has previously served on several other global\, regional and national boards. \nDr. Ali has been and continues to be involved in advocacy and creating awareness on pain relief and palliative care in Kenya for children and adults as well as Universal Health Coverage. In her leadership role as the Executive Director for KEHPCA\, she was very instrumental in fostering strong relationships with the Ministry of Health to integrate palliative care into government hospitals. She was also instrumental in advocating for palliative care to be included in the undergraduate medical and nursing schools in Kenya. She is a strong advocate for cancer prevention\, control and treatment and was instrumental in developing the first National Cancer Control Strategy and the National Guidelines for Cancer Management-Kenya. She has also advocated for palliative care to be integrated in other non-communicable diseases as well as infectious diseases. \nDr. Ali has been involved in a number of activities at the World Health Assembly (Geneva) and the UN High Level Meetings on Non-communicable diseases. She is a strong advocate for right to health for all and a supporter of the movement on meaningful involvement of persons living with serious health conditions and leaving no one behind. \nDr. Ali holds an MD from Ege University\, Izmir\, Turkey\, a Master’s Degree in Public Health from the University of Nairobi\, a Higher Diploma in Palliative Care from Oxford Brookes University and a Masters in Palliative Care from the University of Dundee. She has completed the International Pain Policy Fellow program with the International Pain Policy Studies Group (WHO Collaborating Centre for Policy and Communication in Cancer Care\, University of Wisconsin) as well as Higher Diploma in the International Palliative Care Leadership Development Initiative at The Institute of Palliative Medicine at the San Diego Hospice.\nShe has received a number of awards in recognition of her work nationally and globally. These include: \n\nDoctor of Law Honoris Causa-University of Dundee (2018)\nInternational Humanitarian Award-Women4Africa (2018)\nSocial Impact Award for the Sub-Saharan Africa region-British Council (2018)\nHonorary Doctor of the University by Oxford Brookes University (2012)\nIndividual Advocacy Award by the African Palliative Care Association and Open Society Foundations (2013\nAfrican Palliative Care Award –(In recognition for being on the interim board and later serving on the board for 2 terms) -2007\n\n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/palliative-care/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/06/Unnamed20.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220630T190000 DTEND;TZID=Africa/Nairobi:20220630T203000 DTSTAMP:20260423T224351 CREATED:20220524T083656Z LAST-MODIFIED:20220705T094143Z UID:7656-1656615600-1656621000@kesho-kenya.org SUMMARY:Hodgkin's Lymphoma DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Justin Du Toit \nJustin Du Toit is a Clinical Haematologist who trained at UCT and now works in the Bone Marrow Transplant Unit at Wits Donald Gordon Medical Centre. \nHe is currently working with his colleagues to implement quality management systems in adult and paediatric bone marrow transplantation that will be JACIE-FACT accredited. \nDr Du Toit’s main focus and passion is in bone marrow transplant. He is actively involved in research on haematopoietic stem cell mobilisation\, haploidentical stem cell transplantation and donor specific antibodies. Through his research efforts\, Dr Du Toit strives towards creating best care algorithms to improve patient outcomes. \nModerator: Dr Beatrice Jepngetich Melly \nBeatrice Melly is a Clinical Haematologist at Moi Teaching & Referral Hospital. \nShe holds a Bachelor’s Degree in Medicine and Surgery from Moi University and a Master’s Degree in Clinical Haematology from Alexandria University\, Egypt. \nDr Melly is also the Section Head for Haematology at the Haemato-Oncology Directorate at Moi Teaching and Referral Hospital. \nShe has over 8 years’ experience in treatment of both benign and malignant Haematological conditions.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/lymphoma/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/05/unnamed-8.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220616T190000 DTEND;TZID=Africa/Nairobi:20220616T203000 DTSTAMP:20260423T224351 CREATED:20220524T074620Z LAST-MODIFIED:20220617T112938Z UID:7652-1655406000-1655411400@kesho-kenya.org SUMMARY:Immunotherapy DESCRIPTION:[vc_row][vc_column][vc_column_text]PEAKER PROFILES: \nDr Joseph Abuodha \nMBCHB (MOI)\, MMED-INTERNAL MEDICINE (AKU)\, MRCP-UK (EDIN) FELLOW MEDICAL ONCOLOGY  \nDr Abuodha obtained his undergraduate degree from Moi University\, after which he was involved in clinical trials with KEMRI/CDC and later entered the oncology world at AMPATH-KENYA. He pursued his speciality training in Internal Medicine at the Aga Khan University Hospital\, Nairobi and is currently the inaugural Fellow in Medical Oncology at the Department of Haematology and Oncology at the institution after spending a brief period as an instructor. \nHe is also a member of the Royal College of Physicians of Edinburgh\, United Kingdom. \nDr Abuodha has a keen interest in research for health in oncology and building capacity for medical research in the larger Eastern Africa. \nDr Amina Kidee (Moderator) \nDr Amina Kidee is a Medical Oncologist at the Aga Khan University Hospital\, Mombasa. \nHer interests are in breast cancer\, GI malignancy\, and translational research.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/immunotherapy/ CATEGORIES:CME 2022,Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/05/unnamed-7.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220602T190000 DTEND;TZID=Africa/Nairobi:20220602T203000 DTSTAMP:20260423T224351 CREATED:20220531T105446Z LAST-MODIFIED:20250621T200545Z UID:7674-1654196400-1654201800@kesho-kenya.org SUMMARY:Cancer Survivorship DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Kelli Gross \nKelli Gross\, MD\, is a fellowship-trained urologist specializing in Male Infertility and Men’s Health. She completed her undergraduate work at the University of Texas at Austin\, graduating with a BA in Studio Art and a BS in Psychology and. She earned her medical degree from the University of Texas Medical Branch and completed her residency at the Mayo Clinic in Arizona. Dr. Gross elected to pursue an additional year of training at the University of Utah focusing on Male Infertility and Men’s Health. \nShe had extensive training in microsurgery\, including Microdissection Testicular Sperm Extraction (microTESE)\, microscopic varicocelectomy\, microsurgical spermatic cord denervation and Vasectomy Reversal. She also received additional training in men’s health procedures such as placement of inflatable penile prosthesis (IPP) and Peyronie’s disease. Her practice consists of Male Infertility\, Men’s Health\, Erectile Dysfunction\, Peyronie’s disease and surgical management of Testicular Pain and Benign Prostatic Hyperplasia. \nProf Daniela Wittmann \nDaniela Wittmann is an Associate Professor in the Department of Urology at Michigan Medicine. She is also a certified sex therapist and sex therapy supervisor. Her clinical practice is focused on couples coping with sexual problems after prostate cancer as well as on patients with other sexual problems. \nDr. Wittmann’s research interests center on sexual recovery after urologic cancer treatment.  Her research employs mixed methods study design. Dr. Wittmann lectures nationally and internationally on sexual health in chronic illness\, she supervises of Michigan Medicine certified sex therapists\, mentors trainees and colleagues on mixed methods research and is engaged in education about sexual health topics for patient support groups. \nShe has published widely on her research topics and is the Associate Editor of the Journal of Sexual Medicine. \nDr Jane Machira \nJane Machira is an Obstetrician and Gynecologist with a passion for fertility treatment. She is the co-founder of Gynacare and also works as a specialist Obstetrician/Gynecologist at Kenyatta National Hospital (KNH). \nDr. Machira holds a Bachelors of Medicine and Surgery\, a Masters of Medicine in Obstetrics and Gynecology degree from the University of Nairobi and a Master degree in the Biotechnology of Human Assisted Reproduction and Embryology from the Universitat De Valencia in Spain. \nIn addition\, she has done extensive training both locally and abroad in the areas of gynecology\, fertility and laparoscopic surgeries\, having attended training in infertility medicine in Gujarat\, India and the International School of Medicine in Kiel\, Germany\, among others. \nWith over 15 years of experience in reproductive health. She has also lectured at various institutions\, including Kenyatta University’s School of Medicine and is currently a consultant Gynecologist at Kenyatta National Hospital and an honorary lecturer in Obstetrics and Gynecology at the University of Nairobi’s School of Medicine. \nShe is certified by the Kenya Medical and Practitioners Board and is a member of the Kenya Obstetrics and Gynecology Society. She is also a member of the Infertility Committee at KNH\, where she is currently involved in setting up an assisted reproductive department that will provide affordable intrauterine insemination (IUI) and IVF services for the public. \nModerator: Muthoni Mate \nMuthoni Mate is a professional epidemiologist with over 15 years’ experience in health research and health systems strengthening within the African Continent. Her experience with end-to-end implementation of medical research programs and her aptitude for community-rooted solutions lend themselves very strongly to the type of solutions that Africa is moving towards. This involves the designing and implementing of innovative African health solutions with a global mindset. \nMuthoni is a person living with Cancer and her experience crystalized the realities of lack of reliable information\, under resources and a fragmented healthcare system on the outcomes of a cancer diagnosis. This redefined her world view and reaffirmed her contribution in the battle against all types of cancer which lead to the establishment of The Cancer Café (www.cancer-cafe.org) – an innovative nonprofit organization that tailor- makes solutions for people living with cancer by linking them to resources and simplified\, holistic\, credible\, consistent information about cancer prevention\, management and rehabilitation. \nMuthoni has been involved in the generation and implementation of key governance in cancer prevention and management -The Kenya Cancer Policy 2019-2020 and the Kenya National Cancer Control Strategy 2012 – 2020 among others. \nShe also seats on various technical advisory forums\, The National Cancer institute of Kenya and the Non-Communicable Disease ICC Monitoring\, Evaluation and Research. She is also a Rotarian – a humanitarian institution with the mission of service above self.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/survivorship/ CATEGORIES:CME 2022,Continuing Medical Education (CME) ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/05/unnamed-6-e1750536314260.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220526T190000 DTEND;TZID=Africa/Nairobi:20220526T203000 DTSTAMP:20260423T224351 CREATED:20220524T072106Z LAST-MODIFIED:20220531T110834Z UID:7650-1653591600-1653597000@kesho-kenya.org SUMMARY:The Economics of Cancer Care DESCRIPTION:[vc_row][vc_column][vc_column_text] \n\nSPEAKER PROFILES: \nProf Nazik Hammad \nNazik Hammad is a Professor at the Division of Medical Oncology\, Queen’s University\, Kingston Health Science Center\, Ontario\, Canada. She is the Chair of the Education and Training Committee of the African Organization in Research and Training in Cancer (AORTIC). Prof. Hammad is a visiting professor at the University of Nairobi\, Kenya. She is the co-chair of the Network for Advancing Black Learners (Medical Students and Residents) in Ontario. She is the former Director of Global Health\, Faculty of Health Sciences at Queen’s University. She is an executive member of the Global Oncology Program at Queen’s University. She treats GI\, breast and brain tumours. \nProf. Hammad has a keen interest in medical education\, in particular health professions education in low and –middle-income countries (LMIC) and cancer workforce development.  She has a Master degree in Medical Education in the Health Professions (MEHP) from Johns Hopkins University. She teaches regularly at the Clinical Oncology Training Program in Khartoum\, Sudan and as a visiting professor at the Medical Oncology Fellowship Training Program\, University of Nairobi\, Kenya. Her areas of expertise include training program development and evaluation\, accreditation\, curriculum development\, mentoring and innovations in education. Her work on education has been presented at international conferences and published in peer-reviewed journals. She is a recipient of several grants in education including the Royal College of Physicians and Surgeons of Canada International Development\, Aid and Collaboration Grant in 2020 for Faculty Development among African Oncologists.  Her other areas of interest include value in cancer care. Together with colleagues in African she led the first Choosing Wisely Africa that was recently published in the Journal of Global Oncology. \nProf Fredrick Chite Asirwa \nFredrick Chite Asirwa M.D. is the CEO of International Cancer Institute\, an organization whose main purpose is to expand Education\, Clinical Care and Training opportunities in cancer control and research across sub-Saharan Africa (SSA) through multi-sectoral collaborations and partnerships with relevant organizations both governmental and NGOs. \nHe is a Medical Oncologist & Hematologist\, PD/PI of several access to personalized cancer care and research initiatives including Blueprint Program\, Shining Tower Program\, Clinical Trials Program-all geared towards enhancing early detection\, promoting primary HPV screening\, providing SOC diagnostics\, therapeutics cancer research. He has developed several training programs including SSA Oncology Preceptorship training\, Digital Pathology Program\, Telemedicine Program\, Oncology training for Physician assistants (Clinical Officers)\, development of Oncology Nursing training program in Kenya\, Medical Oncology Fellowship Program and assisted in the development of gynecologic oncology program. . He also conducts Clinical Trials in SSA. \nHe was previously (2011-2019)\, the Director of Academic Model Providing Access to Health Care (AMPATH Oncology & Hematology Consortium) in Kenya. In this role he developed infrastructure for telemedicine at AMPATH\, created a robust hematology & oncology outreach program in rural Kenya and participated in the development of the Kenya National Cancer Control policies\, strategic plans and guidelines by the National MOH. As PI to various clinical and research programs he established Multiple Myeloma program\, Lymphoma Program\, functional tumor registry\, Breast Cancer screening & treatment program\, Hemophilia and Sickle cell diagnostics\, treatment & research\, EMR for Oncology care and screening\, a multinational Lung Cancer Control Program\, MLCCP (Kenya\, South Africa\, Lesotho\, Tanzania\, and Eswatini). He also teaches at various Universities in SSA and participates in Scientific Review Committees (SRC) of various Oncology Clinical Trial Centers in SSA. \nHe has also been an active ASCO member through ASCO’s Multidisciplinary Cancer Management Course (MCMC)\, International Affairs Committee (IAC)\, Education Council\, ASCO‘s Academic Global Oncology Task Force and as a Peer reviewer to ASCO Journals. He is currently a member of ASCO-ESMO Global Oncology Curriculum committee and was recently elected by ASCO membership to serve on the Board of Directors of the American Society of Clinical Oncology (ASCO) as the designated International Oncologist for 2022-2026. \nHe has been recognized for his work to increase access to cancer control for the underserved through various awards including the United States’ National Cancer Institute’s Pearline Global Cancer Research Humanitarian Award\, 2020; The Children’s Place International‘s 2018 Hero Award for his pioneering work in treating children and adults with cancers in Kenya. He is the current Interim President of the College of Oncology of East\, Central and Southern Africa (ECSA-CO) and a senate member for ECSA Health Community. He is also a distinguished Faculty speaker in both local\, regional and International professional conferences and events including ASCO\, AORTIC\, KESHO\, Africa Cancer ECHO\, APCA amongst others. \nHe did his Undergraduate training (Bachelor of Medicine and Bachelor of Surgery) in Kenya and Post-graduate/specialty training (Internal Medicine Residency & Heme/Onc Fellowship) in the United States. \nDr Solomon Matiko Riro \nMatiko Riro is a Medical Doctor and a Health Economist\, currently supporting a number Sub-Saharan African countries in health financing reforms towards achieving UHC. He has been involved in several advisory and research initiatives focusing on optimizing health outcomes\, specifically on cost-effectiveness and budget impact of healthcare interventions in low- and middle-income countries. \nModerator: Dr Mohammed Ezzi  \nMohammed Ezzi is a Lecturer and Consultant Medical Oncologist in the Department of Clinical Medicine and Therapeutics at the University of Nairobi in Nairobi\, Kenya. He is also the Treasurer for the Kenya Society of Hematology and Oncology (KESHO) and also the Chair for the Educational subcommittee in the same Society. \nHe did his Internal Medicine residency at the University of Nairobi and subsequently did a two-year fellowship in Medical Oncology at the same university. He is currently a fellow at the College of the European School of Oncology and pursuing a Certificate in Competence in Breast Cancer by the European School of Oncology. \nHis academic focus is in medical education and is passionate about teaching across the spectrum of medical learners with an interest in enhancing oncologic knowledge among non-oncologist. He has presented at several symposia\, workshops and conferences both locally and internationally. He has several publications in peer reviewed international journals. Dr. Mohammed Ezzi is a member of KESHO\, ASCO\, ESMO\, AORTIC and KAP. His key areas of interest include breast cancer\, malignant hematology and clinical pharmacology. \n  \n\n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/economics-of-cancer-care/ CATEGORIES:CME 2022,Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/05/unnamed-5.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220519T190000 DTEND;TZID=Africa/Nairobi:20220519T203000 DTSTAMP:20260423T224351 CREATED:20220421T072608Z LAST-MODIFIED:20230330T105635Z UID:7545-1652986800-1652992200@kesho-kenya.org SUMMARY:Ovarian Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Vineet Talwar \nVineet Talwar is a Medical Oncologist. He currently serves as the Director\, Department of Medical Oncology at RGCIRC\, New Delhi\, India a position he has held since May 2002. He holds a Doctorate of Medicine in Medical Oncology from the Cancer Institute\, Adyar\, in Chennai. \nHis areas of interest include: Ovarian Cancer\, Breast\, Cervical\, Pancreatic\, Lung\, Urinary Bladder\, Gallbladder\, Stomach\, Renal\, Chronic Myeloid Leukemia\, Acute Myeloid Leukemia\, Lymphoma and Testicular Cancer. \nProfessional Associations: \n\nFellow of Royal College of Physicians (FRCP) EDINBURGH (U.K).\nFellow of Indian College of Physicians (FICP )\nFellow of International Medical Sciences Academy (FIMSA)\nMember European Society of medical Oncology (ESMO)\nMember American Society Of Clinical Oncology (ASCO)\nLife Member India Society of Oncology (ISO)\nLife Member Breast Cancer Foundation India (BCFI)\nLife Member Indian cooperative Oncology Network (ICON) Group\n\nDr Vineet has published widely in peer reviewed journals. He has received numerous national awards in recognition of his work. \nDr Khadija Warfa \nKhadija Warfa is a Consultant Gynecologic Oncologist\, who completed her gynaecological oncology fellowship at the University of Calgary\, Canada. \nCurrently Dr. Warfa is an Assistant Professor in the Department of Obstetrics and Gynecology at The Aga Khan University Hospital\, where she had done her Obstetrics and Gynecology residency training. She is involved in the training and supervision of postgraduate students. \nDr. Warfa is a member of the African Cancer Coalition and European society of gynecologic oncology (ESGO). She is involved in the Harmonized NCCN guidelines and is a technical advisor to the Kenya National cancer treatment protocols with the objective to reduce mortality related to Gynecologic Cancers in Kenya. \nModerator: Dr Benjamin Odongo Elly \nBenjamin Odongo Elly is a Senior Lecturer\, Obstetrician/Gynaecologist and Gynecologic Oncologist with over 20 years of experience in clinical practice and programmatic leadership of public health initiatives. \nHe previously served as the Head of Department of Gynaecologic Oncology at Moi Teaching and Referral Hospital (MTRH) Eldoret\, a position he had held since completion of Clinical Fellowship Training in Gynaecologic Oncology (Moi University/University of Toronto) including International Gynecologic Cancer Society(IGCS) Global Mentorship Program. \nPrior to his current engagement\, Dr. Elly was The Technical lead of Prevention of Mother-to-Child Transmission of HIV/Maternal and Child Health (PMTCT/MCH) at the U.S. Centers for Disease Control and Prevention (CDC). \nDr. Elly has held various teaching positions\, balancing lectures with clinical duties and student mentorship. He is a published researcher and in the process of developing multiple protocols. He has presented at International and local conferences and participated in various reproductive health discussion forums. \nDr. Elly is the former President of The Kenya Obstetrical and Gynecological Society (KOGS). \n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/ovarian-cancer/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/04/unnamed-4.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220512T190000 DTEND;TZID=Africa/Nairobi:20220512T203000 DTSTAMP:20260423T224351 CREATED:20220510T120450Z LAST-MODIFIED:20230330T105627Z UID:7608-1652382000-1652387400@kesho-kenya.org SUMMARY:Cancer Policy in Action DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES: \nDr Felipe Roitberg \nFelipe Roitberg is a clinical oncologist at the Hospital Sirio Libanes in São Paulo\, Brazil\, and a WHO Consultant for Cancer Management and Control. \nDr Roitberg completed his clinical oncology fellowship at the Hospital Israelita Albert Einstein\, Sao Paulo\, in 2011. He also had the opportunity to educate himself in the public health field while following courses in Healthcare Management\, Quality for Healthcare Services and Economics for healthcare organizations at Harvard School of Public Health. \nHe has worked in clinical research in the ICESP/University of Sao Paulo for 10 years\, and is currently involved with economics for healthcare analysis\, including an ongoing systematic review on financial toxicity for cancer patients in partnership with the World Health Organization and the International Agency for Cancer Research (IARC). He is also an active member and alumni of the UICC Young Leadership Program and a member of the Brazilian Society of Clinical Oncology International Affairs Board. \nDr Roitberg has presented at international conferences and workshops and has published several articles in peer-reviewed journals. He works as a peer reviewer for high-impact scientific journals such as the Journal of Global Oncology and Frontiers in Oncology\, and his latest achievements in this field came when he was asked to serve as a reviewer of the 2020 WHO Report on Cancer and to join the Editorial Board of the Journal of Cancer Policy. \nDr Roitberg is an active and engaged ESMO member\, including his activities as a member of the ESMO Global Policy Committee and the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) extended Working Group. \nDr Mary Nyangasi \nDr. Mary Nyangasi is a public health specialist/epidemiologist with interests in Non-Communicable Disease especially Cancer. She earned her medical degree from the University of Nairobi and a Masters in Public Health in Epidemiology and Disease Control from Kenyatta University. She holds postgraduate certificates in Non-Communicable Diseases and Diplomacy from Graduate Institute Geneva and Leadership and Management in Health from the University of Washington. \nShe has experience spanning over 15 years in clinical practice and public health with 7 years of specialist oncology practice and currently working in the area of cancer control programming and policy. She is a member of the African Cancer Coalition and has contributed to the development of NCCN harmonized guidelines for head and neck cancers as well as the conceptualization and implementation of Chemosafe project in Kenya. \nDr. Nyangasi is the Head of the National Cancer Control Programme in the Ministry of Health within the Department of Non-Communicable Diseases\, the arm within the Ministry that coordinates the implementation of cancer control activities on behalf of the Ministry. \nHer main interests are in breast\, cervical and colorectal cancers prevention and control\, research\, innovations in public health for strengthening the health systems and implementation science. \nShe enjoys cooking especially trying out healthy menus\, travelling\, meeting new people\, networking\, and sharing ideas. She is also an avid reader. \nDr. Nyagasi mentors women in her community and participates in community awareness and sensitization on health topics of interest. \nDr Alfred Karagu \nAlfred Karagu is a public health specialist with over 16 years’ experience in clinical care\, health services management\, monitoring and evaluation\, training and public health research. He holds a Bachelors degree in Medicine and Surgery and a Master of Science in Health Systems Management and is a graduate of the Field Epidemiology and Laboratory Training Programme\, a competency-based training by the Ministry of Health and United States Centre for Disease Control. \nHe has a vast experience in program management in both the infectious and non-communicable disease prevention spheres having worked in the public health sector across the national and county government levels. He currently serves as the Chief Executive Officer of the National Cancer Institute of Kenya\, a statutory body established under the Cancer Prevention and Control Act of 2012 to coordinate and regulate cancer prevention and control activities. He is thus spearheading the development of policies\, guidelines and standards to enhance access to cancer treatment\, quality improvement initiatives for better treatment outcomes and improved cancer data management to inform policy and practice. \nDr. Karagu has a keen interest in health system research with a number of publications in peer-reviewed journals and presentations at local and international conferences. He is passionate about strengthening health systems to respond to the rising burden of non-communicable diseases through innovations and effective partnerships \nModerator: Dr Miriam Mutebi  \nDr. Miriam Mutebi is a Consultant Breast Surgical Oncologist and Assistant Professor in the Department of Surgery at the Aga Khan University Hospital in Nairobi\, Kenya. She is also a clinical epidemiologist and health systems researcher with a research focus on understanding barriers to access for women with cancers in Sub-Saharan Africa and in designing interventions to mitigate those barriers. \nShe is the President Elect of the African Organization for Research and Training in Cancer (AORTIC)\, the Chairperson for the Kenya Society of Hematology and Oncology (KESHO) and on the board of directors of the Union for International Cancer Control (UICC).  She is also the co-founder of the Pan African Women’s Association of Surgeons (PAWAS-www.africanwomensurgeons.org) which was developed to mentor and provide transformative leadership for women in surgery in order to improve surgical care and pathology on the continent and is part of the Kenya Association of Women Surgeons. \nShe is the Co-chair of the National Cancer Taskforce in Kenya\, Chair of the Commonwealth Taskforce for the elimination of Cervical Cancer and a commissioner with three Lancet commissions of Women and cancer\, Cancer in sub-Saharan Africa and Breast Cancer. She is currently pursuing a pilot’s licence in order to extend breast care services to marginalised areas.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/cancer-policy-in-action/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2022/05/unnamed-13.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220505T190000 DTEND;TZID=Africa/Nairobi:20220505T203000 DTSTAMP:20260423T224351 CREATED:20220421T072358Z LAST-MODIFIED:20230330T105652Z UID:7543-1651777200-1651782600@kesho-kenya.org SUMMARY:Head and Neck Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILE: \nDr David Musyoka \nDr Musyoka is a Consultant ENT\, Head & Neck Surgeon at Aga Khan University Hospital\, Nairobi​. \nHe holds a Bachelor of Medicine and Surgery from the University of Nairobi and a Master of Medicine Ear\, Nose and Throat Surgery from the same institution. He did his fellowship in Head and Neck at the EDA Hospital\, Taiwan. \nDr Musyoka’s areas of interest are head and neck cancers. \nHe is an Associate Member of the Kenya ENT Association. \nDr Mohsen Mokhtar \nChief Medical Director Dr. Mohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School\, Cairo Egypt. Dr. Mohsen assisted in developing the syllabus and course structure at Al-Kasr Al-Aini\, as well as\, supervised several research programs and theses. \nDr. Mokhtar has published more than 50 articles in several regional magazines in topics including: breast\, lung\, pediatric\, colorectal\, ovarian malignancies NHL and hematologic malignancies. Professionally\, Dr. Mokhtar has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities. \nModerator: Dr Chege Macharia  \nDr Macharia is a Head and Neck Oncologic and Trauma surgeon\, and currently the Head of Department\, Otolaryngology\, Head and Neck Surgery at AIC Kijabe Hospital. \nHe earned his medical degree at the University of Nairobi\, then a fellowship in General Surgery with COSECSA and PAACS\, and subsequently and Fellowship in Head and Neck Surgery with PAACS/Johns Hopkins. \n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/head-and-neck-cancer-2/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/04/unnamed-3.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220428T190000 DTEND;TZID=Africa/Nairobi:20220428T203000 DTSTAMP:20260423T224351 CREATED:20220421T071950Z LAST-MODIFIED:20230330T105659Z UID:7541-1651172400-1651177800@kesho-kenya.org SUMMARY:Iron Overload In Haematological Diseases DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILE: \nProf Walter O. Mwanda \nProf Walter Mwanda Is a Professor of Haematology and Blood Transfusion\, qualified as a Medical Doctor MBCHB\, postgraduate training in Pathology specialized in Haematology and Blood Transfusion and Oncology. \nProf Mwanda attained terminal degree of doctor of Medicine in haematology. In 1992 he joined the Faculty at the University of Nairobi; Haematology and Blood Transfusion that also runs Oncology services for the Kenyatta National Hospital – the largest teaching and referral hospital in the region. Has been the Chairman of the Department of Human Pathology\, Haematology and Blood Transfusion and Director at the University of Nairobi Institute of Tropical and Infectious Disease. \nProf Mwanda Is a member and Chair of several professional bodies both national and international. He is widely published in oncology and haematology with pitch in haematology\, blood transfusion\, paediatrics oncology and infections related malignancies. Prof Mwanda has supervised several students at undergraduate\, masters and PhD levels. \nHe is a keen researcher in oncology\, haematology and allied specialties. Has been the Head of Paediatric Oncology since 1994 and greatly experienced as lecturer\, medical doctor\, researcher and mentor. \nProf Mwanda is keen on producing generations of mentors\, supervisors and trainers in all areas of interest. \nModerator: Dr Paresh Dave \nParesh Dave is currently the Director and Clinical Pathologist and Hematology/Oncology practitioner at Meditest/Mediforte Hospital. \nHe is an Honorary Lecturer in Haematology and Blood Transfusion University in the Thematic department of Haematology and Oncology College of Health Sciences University of Nairobi. \nDr Dave qualified with MBChB degree in 1988 and M.Med (Path) in 1994 both from the University of Nairobi. He obtained his Fellowship at the Royal College of Pathologists of Australasia (Haematology) in 2005. Dr Dave worked at Monash Medical Centre and Dandenong Hospital Australia for 2 years (2000-2002) as a Registrar\, and at Kenyatta National Hospital from 1995 to 2005 as a Medical Specialist and Senior Medical Specialist in haematology. Between 2005 and 2012 Dr Dave worked as Pathologist in Charge and Clinical haematologist at the M.P Shah Hospital\, and went on to join Medanta Nairobi as Haematologist and Oncologist from 2012 to 2016. \nDr Dave has keen interest in Luekaemias\, Myelomas and solid malignancies \n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n Register \n [/vc_column][/vc_row] URL:https://kesho-kenya.org/event/iron-overload/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/04/unnamed-2.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220421T190000 DTEND;TZID=Africa/Nairobi:20220421T203000 DTSTAMP:20260423T224351 CREATED:20220404T095420Z LAST-MODIFIED:20230330T105706Z UID:7420-1650567600-1650573000@kesho-kenya.org SUMMARY:Esophageal Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILE: \nDr Njoki Njiraini \nNjoki Njiraini is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in The Nairobi Hospital. \nShe has been key in instituting multidisciplinary meetings\, problem oriented research in the department\, and streamlining patient care within the oncology clinics in the public and private sector. \nDr Njiraini holds a Bachelor’s degree in Medicine and Surgery from the University of Nairobi\, a Master’s Degree in Radiation Oncology from the University of Cape Town\, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and  a graduate of the Harvard POETIC Fellowship programme. \nDr Morris Muhinga \nMorris Muhinga is a Consultant Thoracic and Cardiovascular Surgeon at Kenyatta National Hospital. \nHe has special interest and passion in thoracic oncology. He is currently engaged in a prospective multinational study on the morbidity and mortality of oncological esophagectomy (OUTLIVE study) \nDr Muhinga is a committee member of International Society for the Diseases of the Esophagus (ISDE)\nHe is a member of; \n\nThe Society of Thoracic Surgeons (STS)\nThe Society for Surgery of the Alimentary Tract (SSAT)\nThe Society of Surgical Oncology (SSO)\nThe International Gastric Cancer Association (IGCA)\n\nModerator: Dr Manel Haj Mansour \nManel Mansour is a consultant physician and board certified medical oncologist currently working at the Aga Khan University Hospital. She was formerly a consultant medical oncologist at Texas Cancer Centre\, Nairobi and also worked as a consultant medical oncologist and a lecturer at Abderrahmen University Hospital\, Tunisia. \nDr Mansour graduated from the Faculty of Medicine of Tunis in 2012 and completed medical oncology residency in 2017. \nShe holds: \n\nA certificate of completion of Oncologic Science Course on line in Breast Cancer treatments from The Africa Breast University.\nA certificate of medical oncology training on XXXIIth course antitumor chemotherapy and cancer medical treatment at Gustave Roussy Institute Paris\, France.\nA post graduate certificate in Prevention and Palliative Care in Oncology\, Faculty of Medicine of Sousse.\nA post graduate certificate in Thoracic Oncology\, Faculty of Medicine of Tunis.\nA post graduate certificate in Breast Disease\, Faculty of Medicine of Tunis. She is a member of ESMO\, ASCO\, STOM (Tunisian Society of Medical Oncology) and KESHO. Her areas of interest include breast cancer\, lung cancer\, gastrointestinal cancers\, gynecological and genitourinary cancers.\n\n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/esophageal-cancer/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/04/unnamed-1.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220414T190000 DTEND;TZID=Africa/Nairobi:20220414T203000 DTSTAMP:20260423T224351 CREATED:20220404T092031Z LAST-MODIFIED:20230330T105713Z UID:7410-1649962800-1649968200@kesho-kenya.org SUMMARY:Metastatic Triple Negative Breast Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILE: \nDr Sitna Mwanzi  \nSitna Ali Mwanzi is currently a Consultant Medical Oncologist working at the Kenyatta National Hospital\, Nairobi. She is the former Chair of the Kenya Society of Haematology and Oncology (KESHO) which is a professional organization whose aim is to reduce the cancer burden and mortality in Kenya through education\, research and advocacy initiatives. \nDr Mwanzi attained her Bachelor of Medicine and Surgery from the University of Nairobi and Master of Medicine in Internal Medicine from the Aga Khan University Hospital\, Nairobi. She undertook a fellowship in Medical Oncology at Barts Health NHS Trust in the United Kingdom attaining a Specialist Certificate in Medical Oncology from the Royal College of Physicians and Association of Cancer Physicians in the United Kingdom. She also has a Master of Science in Advanced Oncology from Ulm University in Germany. She has recently been recognized as a Fellow of the Royal College of Physicians\, Edinburgh (FRCP). \nHer research interests include breast cancer\, prostate cancer\, chronic myeloid leukemia and cervical cancer. She is passionate about increasing health care worker and general public awareness about cancer\, role of screening\, early diagnosis and treatment of cancer. \nDr. Mwanzi works closely with the National Cancer Control Program in implementation of the National Cancer Control Strategy. She has also been involved in the development of national guidelines for Kenya and harmonization of the National Comprehensive Cancer Network (NCCN) guidelines for Sub-Saharan Africa. \nModerator: Dr Angela McLigeyo  \nAngela McLigeyo is a licensed Physician and Medical Oncologist practicing in Kenya. She has a Master of Medicine in Internal Medicine from the University of Nairobi\, a M.Sc. in Clinical Oncology from Ulm University (Germany)\, and a Fellowship in Medical Oncology from the University of Nairobi. In addition\, she obtained a 5-year board certification in Medical Oncology from ESMO in 2019. She has over 17 years of experiences in hospital and clinical settings. \nDr McLigeyo is the current Secretary of the Kenya Society of Hematology and Oncology (KESHO)\, European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). She is also a fellow of the East\, Central and Southern Africa College of Physicians. \nHer core skills are in clinical decision making in internal medicine and oncology\, conducting trainings\, streamlining medical education and conducting research as well as participation in the development of treatment guidelines and protocols. \nDr McLigeyo currently provides comprehensive oncology healthcare at both public and private health facilities\, conducts research in oncology and internal medicine when opportunities arise\, and is engaged in teaching internal medicine and oncology at the Kenyatta University. She has authored several research articles in peer reviewed journals and presented abstracts at several conferences. \n  \n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/metastatic-triple-negative-breast-cancer/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/04/WhatsApp-Image-2022-04-12-at-12.22.48-PM.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220331T190000 DTEND;TZID=Africa/Nairobi:20220331T203000 DTSTAMP:20260423T224351 CREATED:20220303T102508Z LAST-MODIFIED:20230330T105720Z UID:7288-1648753200-1648758600@kesho-kenya.org SUMMARY:Myelofibrosis DESCRIPTION:[vc_row][vc_column][vc_column_text] \nDr Anne Mwirigi  \nDr Anne Mwirigi is a consultant haematologist working at the Aga Khan University Hospital in Nairobi\, Kenya. She obtained her undergraduate MBChB from the University of Glasgow in 2002. After her house jobs and a medical rotation in Glasgow\, she moved to London in February 2007. \nHer career in Haematology began as a senior house officer at King’s College Hospital\, following which she was accepted on the Guy’s and St Thomas’ NHS Trust Specialist Registrar Rotation in 2009. She obtained her certificate of completion of training in 2014\, and thereafter took on consultant haematologist positions for a period of two and a half years at both Guy’s and St Thomas’ and King’s College Hospitals. \nDr Mwirigi has a passion for haematology and always planned to practice haematology in her country of birth\, Kenya. Since moving back in December 2016\, she has engaged with haematopathologists and clinical haematologists in the region\, and is involved collaborative ventures aimed at improving the quality of haematology services in Kenya. She was a key member of the scientific committee which organised the Haematology and Oncology Society of Africa 3rdinaugural conference held in Nairobi in August 2017. \nDr Paresh Dave (Moderator) \nDr Paresh Dave is a clinical pathologist and Haemato-Oncologist. He is the current Director at Meditest/Mediforte Hospital as well as a haematology and Oncology practitioner at the same institution. \nHe obtained a Fellowship of the Royal College of Pathologists of Australasia. Dr Dave previously worked at KNH as a haematologist and as a Clinical Pathologist and haematologist at M.P. Shah Hospital. \nDr Dave is an honorary lecturer in Haematology and Blood Transfusion at the Thematic Department of Haematology and Oncology\, College of Health Sciences University of Nairobi. \n  \n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/myelofibrosis/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2022/03/unnamed-12.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Africa/Nairobi:20220317T190000 DTEND;TZID=Africa/Nairobi:20220317T203000 DTSTAMP:20260423T224351 CREATED:20220303T101628Z LAST-MODIFIED:20230330T105744Z UID:7280-1647543600-1647549000@kesho-kenya.org SUMMARY:Kidney Cancer DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILE: \nProfessor Nicholas Othieno-Abinya  \nNicholas Anthony Othieno-Abinya is a Consultant Medical Oncologist at the Nairobi Hospital Cancer Centre. He was formerly Professor of Medicine at the University of Nairobi\, Kenya\, where he was the director of Medical Oncology Fellowship Program and also the head of Haematology/Oncology at the University of Nairobi and Kenyatta National Hospital\, Nairobi. In 2009 and 2010 he was Head of Oncology at Aga Khan University Hospital\, Nairobi. \nHe holds a Master’s degree in Internal Medicine of the University of Nairobi\, completed fellowship in Medical Oncology at the Royal London Hospital (University of London) in 1992\, and is a Fellow of the Royal College of Physicians of Edinburgh. \nHis research interests are in malignant haematology and breast cancer\, in which he has published widely in peer-reviewed journals. He also has keen interest in molecular oncology. He has also authored  a text book titled Drug Treatment of Haematologic Neoplasms. He has also co-authored cancer booklets\, and has written chapters in several books. His latest book titled ‘Shadow in Perpetuity’ by Lambert Publishers was released in December 2019. \nDr. Othieno-Abinya is a member of American Society of Clinical Oncology (ASCO)\, and served in its International Affairs Committee from 2010-2012; Africa Organization for Research and Training in Cancer (AORTIC)\, having been Vice Chair for Eastern Africa and was a long time member of Council; and European Society for Medical Oncology (ESMO). He founded Kenya Society of Haematology and Oncology (KESHO)\, of which he was the first Chair\, and is still its Patron. His outstanding academic achievements were profiled in the University of Nairobi magazine\,’ Varsity Focus’ of September 2017. \nHe has received several awards and honours\, including the Kenya Breast Health Programme Award in appreciation of contribution to success of the Breast Cancer Survivors’ Conference on 11-14 July 2003; Kenya Breast Health Programme Award in recognition for outstanding contribution to the care of women with breast cancer in Kenya; Best Oral Presentation by Established Scientist Award\, 2ND KASH Conference\, Kenya Medical Research Institute\, Nairobi;  2018 Harvard Global Health Catalyst: Distinguished African Ambassador Award. \nModerator: Dr Njoki Njiraini \nNjoki Njiraini is a Consultant Clinical Oncologist based at the Cancer Treatment Centre in The Nairobi Hospital. \nShe has been key in instituting multidisciplinary meetings\, problem oriented research in the department\, and streamlining patient care within the oncology clinics in the public and private sector. \nDr Njiraini holds a bachelor’s degree in Medicine and Surgery from the University of Nairobi\, a Master’s Degree in Radiation Oncology from the University of Cape Town\, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme. \n  \n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column] \n \n Webinar Recording \n \n \n [vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"] \n Access our Membership Page \n [/vc_column_inner][vc_column_inner width="1/3"] \n Fill in the Membership Form \n [/vc_column_inner][vc_column_inner width="1/3"] \n Access Membership Portal \n [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row] URL:https://kesho-kenya.org/event/kidney-cancer/ CATEGORIES:CME 2022,Continuing Medical Education (CME),Webinar Recording Available ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2022/03/unnamed.jpg END:VEVENT END:VCALENDAR